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It 1b ?/ell eetablished that sodium Balicylat< 
in moderate dosage^ InoreaBes the metabolic rate of 
experimental animals and man. The effect on this 
property of alterations in the eheraical structure of 
salicylate was the subject of the present investigation 
The first part of the present work was to 
determine which eompoimds within a series of eighteen 
siibstltuted benzoatee were active as metabolic 
stimulants in the intact rat. These eighteen compounds 
included the complete series of both the mono and 
dlhydroxybenr^oates and the eroBotinates *
Wlstar albino rats were used throughout the 
invoBtigation and the individual rates of oxygen 
consumption were measured in a closed circuit manometrj 
apparatus.
In these experiments the results wei'e
expreBBed in terms of the difference in rates of 
oxygen consumption between paired$ treated and control 
rate and the mean difference in rate of oxygen 
consumption was estimated fox^  each compound.
The tx’eated rats were given g by intraperiton^ 
injection^ the sodium salts of the test compounds in 
the maximum practical doses tolerated. The control 
animals were given a corresponding volume of normal 
saline.
2g3‘-dihydroxybeni30ie acid^ phthallo acid 
and 6-methylsalicylic acid were, at the doses used# 
inactive. Meta-- and pax’ahydroxyben^oic acid#
2s4*-ÿ 2§5^f 2? 6-# 3 s 4- and 3?5-“dihyd;eoxybengioic 
acid# o-aminobenvoie acid# salicyluric acid# salieylaml 
and 5-aminosallcy 11 o acid decx^ eased the metabolic rate. 
Only the three eresotinic acids# i.e. 3# 4? and 5« 
methylsal1cy11o acid possessed the metabolic stimulant 
property of salicylate.
The relative efficacy of the three cresotinr 
and salicylate as metabolic stimulants was determined 
by comparison of their respective dose-response 
curves# and molar potency ratios of the creBotinatee 
relative to salicylate were ealculated. Ortho-
.2.
ereeotinate was the most powerful with a 3:atio of 2.61. 
me ta- and para.--ereBotinate were of the same order with 
values of 1.78 and 1,89 respectively,
Two possible explanations of the higher 
potencies of the orcsotinates were consideredo Bo 
difference in the primary action of the drugs was 
established by determining the effect on rate of oxygei 
consumption of a mixture of ortho-ei'esotinate aM 
sa3.icylate #
The other possibility coneidered was that 
the rates of détoxication and excretion of the 
creeotinatee differed among themselves and from 
salicylate. lo cliffex^ ences in rates of disappearance 
of the drugs from the blood were found. This finding 
implies that the relative potencies of the oresotinate^ 
and salicylate as metabolic stimulants in the intact 
rat are a reflection of true potency differences at 
the tissue level.
The reports of previous workers have been 
presented and the significance of the present results 
discussed.
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Xnt r oduo t ion.
The salicylates# v/hich were introduced as 
plant extracts centuries ago# were among the first 
drugs to be synthesised for use therapeutically 
(iColbe# 1874), In the late 19th century# Bubb (1875) 
and Strieker (1876) reported on their use as anti­
pyretic and analgesic agents# and In the same year 
MacLagan (1876) published his observations on the use 
of tSalicin and salicylate in the treatment of rheumatic 
fever, Salicylic acid in the form of its sodium 
salt or its acetyl derivative is now recognised as one 
of the best remedies for rheumatic diseases (Moll.G, 
Joint Trials # 1955 and 1957).
Among the numerous pharmacological 
properties of salicylate studied in the last fifty 
years its action as a metabolic stimulant is 
outstanding. This effect has been studied on man# 
doge# cats# rats# rabbits and mice; in vitro# the 
following px^ epai'-atlons a3?e sensitive to this action
of salicylates- rat liver# kidney and brain slices# 
'mouse liver slices# rat diaphragm# tubercle bacilli 
and rat tissue homogenates and mitochondria*
The action on metabolic rate in vivo 
and in vitro of some compounds chemically related 
to salicylate has also received some attention.
The fillet clinical report of salicylate 
as a metabolic stimulant was that of Denis and 
Means (1916)# who studied the influence of therapeutic 
doses of sodium salleylate (up to 6.6 grams per day) 
on the basal metabolic rate of adult men. Using a 
Benedict’s Universal Respiration Apparatus they 
found an increase of 15^ in the basal metabolic rate 
of only one of the three subjects; they did not 
comment on this finding*
Barbour (1919) and Barbour and Devenis (1919) 
reported that 1 gm. of aoetylsalicylle acid produced 
in most normal subjects a definite increase# of 9^ # in 
carbon dioxide excretion# and an overall increase in 
heat production; in febrile patients# the dissipation 
of heat increased by about with a slight decrease
(of 3*5jâ) in the production of heat* This last 
finding was not confirmed by Dodd# Minot and Arena
(1937)# who studied one mibjeot and found that the 
effect of aspirin was an increase in metabolic 
rate during fever as well as when the subject was 
afebrile *
In 1935# Sylla observed that the metabolic 
rate of a woman suffering from salicylate poisoning 
was increasedg which he considered a result of the 
musoulaz' exertion of the deep and rapid respiration 
shown by his patient.
■ Bossier and Buhlman (1950)# studying the 
aeid-base equilibrium of the blood and respiratory 
function followi^ ig the administration of sodium 
salicylate and salieylamidep found that sodium 
salicylate in the usual doses of 8-10 gms* per day 
led to definite hyperactivity of the respiratory 
function’* and a rise in the basal metabolic rate*
They presented tables showing an Increase of 
approximately 30# in the basal metabolic rate of 
noxmial individuals treated with, sodium salicylate# 
but attached little significance to# and made no 
comment on these results, BalHoylamide in oompmrable 
doses did not produce a change in the basal metabolic 
rate*
The above findings made no impact on
pharmacologists ami oliaiciana in the first half of 
the present century; the hypothesis of a direct 
central action of salicylate prevailed but recent 
years have seen the adoption of broader# less dogmatic 
and more constructive views on the pharmacology 
of salicylate*
Oochran (1952) measured the oxygen 
consumption# carbon dioxide output and depth and rate 
of respiration of six subjects by a closed circuit 
ICnipping type spirometer. Th:eee aub'e-^ aoute 
rheumatic fever patients were treated with oral 
doses of aspirin and three normal adults were given 
sodium salicylate intravenouBly* In all cases# a 
marked and progressive increase in 02^ gen oonsusiption 
was observed# In 1954? Coetean repeated this work 
on a,ciitely ill febrile patients# and# contrary to 
the findings of Barbour and Devenis (1919)$ observed 
Ï311 increase in the rate of oxygen consumption* He 
also demonstrated that whereas a single 3 gm, dose of 
sodium salicylate or aspirin was a powerful metabolic 
stimulant# 5 gm@ doses of sodium meta- or para- 
hydroxybengsoate did not significantly increase the 
metabolic rate of convalescent rheumatic fever patients
Alexander and Johnson (1958) measured the 
oxygen eonsumptlom of normal and hypothyroid patiente 
receiving the full# therapeutio doses of aepizln# 
recoîBînended by Coburn (1943) and practiced by 
Held (1948) in this department# and established linear 
relationships between serum salicylate concentration 
and rate of oxygen consumption for both classes of 
patiente♦
Clinically salicylate is now well 
established as a metabolic stimulant *
Meanwhile there have been occasional reports 
on the effect of salicylate on the rate of oxygen 
coneumption of laboratory animals*
As early as 1901# Singer had reported an 
increase in the oxygen consumption of rabbits to whom 
toxic doses of aoetylsalicylle acid had been given.
There were no other reports in this field until 1957 
v/hen Dodd # Minot and Irena (1937)$ gave five normal 
imanaeethetised dogs large doses (0*2 -> 1*5 gme./kilo) 
of salicylate by mouth# or intrs.venous or subcutaneous 
injection# and measured the changes in respiratory 
rate and gaseous exchange in the Benedict-Hoth 
apparatus « The immediate x'esponse was an abrupt increase
•5«
in tlie rate of oxygen conBumption# followed by an
increase in the depth of z^espiration and in the baeal
metabolic %'ate* These authors felt that ’’the changes 
in temperatuz'*ep the eenaation of heat# and the 
increase in gaseous exchange induced by salicylate 
therapy# were of much greater impoxHance in producing 
an increase in the respix^atory rate and depth than 
any direct eentx^ al action of the drug**,
Balochp Donliofferp Me sty an# Bap and Toth# 
(1952)# Meade (1954) and Hall# Tomloh and Woollett 
(1954) confirmed these results on rats# and Tenney 
and Miller (1955) have demonstrated a aimilar increase 
in the rate of oxygen consumption of dogs. More
recently# Reid (195?) has reported a direct
proportionality between the dose of sodium salicylate 
and the x^ ate of oxygen consumption of rabbits,
Baloeh et al (1952) have also studied the 
effect of salicylamide on the rate of oxygen 
consumption and rectal temperature of rats. A 
subcutaneous injection of 100 mgms® salieylamide 
was followed by a marked lowering of body temperature 
(0.5 3*5^F) and a decrease in oxygen consumption of
— 6—
Meade (1954) gave single 50 mgm, doses of 
eertain mono-* and clihydxx>xybensoic molds 
imtraperltomeally to rats and found that salioylio 
acid was the only compound studied which Increased 
the rate of oxygen consumption signifieantly#®eta-» 
hydx‘oxybensoie acid was a depressant and the remaisxing 
mono- and dlhydroxyhenvoie acids wex^ e# in this dosage# 
without effect*
Hall# Toraieh and Woollett (1954)# investigated 
a number of antirheumatie compounds and others 
chemically rela,ted to salicylic add. They found 
that salicylic and acetylsalicyllc add were the 
only oompounds which increased the rate of oxygen 
consumption of rats or mice; 2t5^ and 2:6- 
dihydro2^yhenj30iG acid# Diet a** and para-hydroxyhen^oic 
taeid end salieylamide were ineffective.
In vitro studies have shomi that tissue 
slicesp homogenates and micro-organisms are all 
sensitive to this stimulating action of salicylate.'
Alwoll (1939) reported an increase in the 
oxygen consumption of liver and kidney slices at 
concentrations of 1-14 millimolar salicylic add in 
the ‘presence of citrate buffer hut not in the presence
of phosphate buffer,
Fishgoia# field and Hall (1951) oould 
detect no stimulation of respiration of thick liver 
slices at any concentx^ation of sodium salloylate hut 
observed an increase in rate of oxygen consimiption of 
brain slices at concentrations of 0*06-0.56 n#./!. 
followed by a progressive fall at higher concentrations 
Using much higher concentrations - M/20 or 
M/10 sodium salicylate# ItUtv^k-Ma^n (1942) found a 
considerable decrease in the rate of oxygen 
consumption of liver slices^ She could detect no 
stimula'Rion at any of the eonoentrationa used. M/10 
sodium ortlïo.«*cresotinate was similar in action to 
M/10 sodium salicylate but M/10 benzoate or 
anthranilate had no effect. The respiration of liver 
slices of rats killed after salicylate treatment 
sometimes showed a small increase after four hours; 
inhibition was never observed*
More recently# Bpx’oull (1954) has studied 
the effect of salicylate on the rate of oxygen 
consumption of mouse liver slices# me Ensured by the 
Warburg direct method. He established definite and 
reproducible doae-reBponse cux^ ves in the presence of
•8*
graded coneentrations of sodium salicylate from 
3*5 X to 7*5 X 10^%. There was a progressive
increase in respiratory rates from 3.5 % to
2 2r. 10 M followed by a fall, the mean oxygen
consumption of the treated tissues becoming less than
that of the controls by a concentration of 5 % iC^M
sodium salicylate.
Smith and Jeffrey (1956) pzoduood a marked
Inorease in the rate of oxygen uptake of isolated
%
rat diaphragm at a concentration of 5 x 10'“"'M
sodium salicylate
Bate! and Heim (1954) studied the effect 
of the mono*-hydx*oxybengîoio acids on the rcespiration 
of rat brain homogenates. Respiration in the 
presence of glucose# pyruvate o,r glutamate was 
markedly increased by 1.5 x 10*"^ M sodium salicylate# 
but when succinate or lactate vms used the same 
conoentz'ation inhibited respiration. The me ta- and 
para-hydroxybensüoic acids in similar concentrât ions 
only showed stimulation when glucose was used as the 
substrate.
Kaplan# Kennedy and Davis (1954) found that 
salicylate# me ta- and para-hydroxybenssoate# gent i sate
.a
ami -'Msoroylate all inhibited the oxygen uptake 
of rat kidney and liver homogenates in the presence 
of sueoinate or oC-ketoglutarate. They also found 
that p contrasty to the claims of Alwall (1939) oonoerning 
tissue slicesp 6.7 x 10"*%! salicylate iriliihitecl 
the oxygen tiptake of rat kidney homogenates in the 
presence of citrate.
Brody (1956) has shown that sodium 
salicylate will stimulate the oxygen consumption of 
rat brain mitochondria; he also showed that salicylate 
has an action similas? to 2 g4-dinitrophenol# which 
stimulates oxygen consumption by inhibition of 
oxidative phosphorylation (hoomis & Lipmarmp 194B# 
and Bimon# 1953). Bodium salicylate# aspizHn# 
methyl salicylate and 2:3-dihydroxyben2:oie acid were 
the only compounds e^ camined by Brody (1956) which were 
found to depress oxidative phosphorylation# but he 
did not study the effect of those compounds on 
r e s pi rat ory rat e •
Pemiall# Kalnitsky and Eouth (1956) 
studied the effect of salicylic acid# aallcylurio 
aeidp aoetylsalicylle acid and gentisle acid on the 
in vitro respiration of rat brain homogenates and
1 0 .
mitoehoiidria at o one entra t ions of 2 % 10 M to
2 X 10 M. They foimd that salioylio acid at 
cone entrât ions of 2 % 10**%ü to 2 x 10*'* %l deerreased 
the uptake of Inorganic phosphate of rat brain 
homogenates while the osicygen uptake proceeded 
essentially unchanged with the net result that the 
PiO ratios were thus progrèssively decreased. Similar 
results were obtained with rat brain mitochondria.
Gent isle and seilioyluric acids both showed a slight 
Inhibition of the rate of oxygen uptake of rat brain 
mitochondria at concent rat ions less than 2 x 10*'"*^!.
Experiments with tissue homogenates must 
always he interpreted with caution# since the results 
are often determined by experimental conditions* It 
is noted that Reiss and field (1948)# who are very 
experienced workers # failed to show that 2s4“’dinitro- 
phenol# a powerful metabolic stimulant to tissue 
slices# could stimulate the respiration of tissue 
homogonatee «
Bernheim (1940) heis shown that sodium 
salicylate increased the rate of oxygen consumption of 
tubercle bacilli *. The addition of 1,0 mgms* sodium 
salicylate to the bacteria suspended in 2 cos* M/20
11^
phosphate Mffor (pE6-*7) more than doubled the oxygen 
uptake; 1.0 mgiiu sodium meta*- or para-hydroxybenzoate 
had no action and sodium anthranilate had only a 
slight one. He suggested that the salicylate was 
being oxidised as a substrate# and that salicylate# 
or compounds of similar oonfiguration# might be 
important as normal metabolites of tubercle bacilli and 
that they might play a part in bacterial metaboliam. 
Although this interpretation of Bernheim’s 
is probably wrong in the light of this revievf# it 
did lead to the Impox^ tant discovery of M S  as an 
effective drug in the treatment of tuberculosis; tlmt 
hov'/ever# is another story (lehmaï'mg 1946).
Hitherto only preliminary studies of 
compounds chemically related to salicylic acid have 
been reported. Certain woxkers have investigated 
the effect on the rate of oxygen consumption of a few 
mono- and dihydroxybengioic acids (Meade# 1954 amd 
Hall# Tomich end Woollett# 1954) on the whole animal 
but they used small doses of those dx^ ugs and did 
not pursue their studies long enough to give any
*=^12—
decisive evidence, The presezit investigation was 
ujidertakeii to obtain oamprehensive data on the 
phEtrmaeological activity of compomids related to 
salicylic eicid,
The meo,sûrement of oxygon consumption of 
whole animals is one of the fe\¥ pharmacological 
properties of salicylic acid which can he very 
easily examined in the 1ahoratory# and was therefore 
considered appropriate to use in the present 
investigation, The rat was chosen as the most 
practical experimental animal# the smallest in which 
metabolic rate changes can be easily detected over 
one hour periodso
The compounds studied can be divided into 
three groups g-
(1) Mono^and clilpydrpxyben^oi^ acids, These included 
the three hydroxybensoic acids 5- ortho-^ # me ta-#
and para.-hydroxybenso 10 acid# and the six dihydroxy- 
benaolo aoidea- 2:3-# 2s4**? 2:5-# 2g5-# 3g4**y and 
3 # 5""Clihydroxybensoic acids.
(2) Substituted sallcvllo acids« The compounds 
included in this group were g-^eminosalicylic acid# 
salioylamide# salicyluric acid and the four methyl 
substituted salicylic acide# i.e. 3-methyl# 4""methyl#
-13-.
5-methyl and 6--methylsallcy3„ic aoid,
(3) Ortho-Bubstltuted benzoic acids, o-aminobensoio 
acid and phthalio acid,
The second part of the present investigation 
was to determine# Eind if possible account for# the 
relative potenciee of any compounds found to 
increase metabolic rate.
*14"
Methods,
OxjgBn eonsumption measurement s were made 
using a closed circuit manometrie method descz^ ihed 
by Cameron (1956), Air was pumped fz'om a gas tight 
reservoir by an electrically driven reciprocating 
rubber bellows respiration pump# through the animal 
chamber - a Kilner jar - and returned to the reservoir 
via a soda lime container, A maxiometez" was attached 
to the circuit between the reservoir and the pump 
and a second reservoir emd manometer assembly was set 
up as a thermobarometez". The glass tops of the 
ICilner jars were replaced by meta.1 lids fitted with 
rubber gaskets and two copper pipes for ventilation. 
All connections were made with glass Y-tubes# rubbez" 
tubing or 3/8 ins, copper tubing, The machines were 
kept in a room whose temperature where possible was 
kept between 18 and 20^0,
The calibration constants, k# of the two 
machines were found by measuring the pressure changes
*1 5 '
produced in the system on Introduoing a known volume 
of water* k la the constant relating pressure 
and volume changes in the equation x - kh where % ^ 
volume change (mis.) at and h resultEint
manometez* change (mmo* fluid), k was evaluated from 
k - # 6 ^  where V - gaa volume (mis, ) calculated 
from Boyle’a Law# T - room temperature (A) and 
= 10,025.
The mtmometers# graduated in ïiimso# were 
filled with Brodie-ICreha fluid# density 1,03*
The weighed rat was placed in the Eilner 
jaz’# which was then connected to the apparatus and 
air pumped through the system for five minutes* A 
pressm^e of 100-120 mms, was then built up in the 
reservoir and the ai*r circulated for ten minutes 
before talcing the first manometer reading, Readings 
of the two manometers and the room temiperature were 
recorded at fifteen minute intervals over a one 
hour period, From the final corrected px^ essure 
change# the volume of oxygen consumed was calculated, 
The results of o^ cygen consumption measurements were 
exp?eased in mis ,/hou3? at
-16*
In the first experiments# Wietar albino 
rats of weight range 230--290 gms. were used* The 
animals were paired for sex and weight and# in each 
run? one animal received the teat solution while the 
other reeeived an Identical volume of normal saline. 
Equal numbers of male and female rate were used#
The drugs vjere administered by intraperitoneal 
injection as solutions of the sodium salts# pH7-*9; 
the doses administered were the highest practical 
doses tolex^ ated by the rats # Table I shows the 
compounds i^ sed# the source from which they were 
obtained# the concentration of the solution injected 
and the dose administered.
Doae^-respOHse experiments* The compounds used 
in these experimente were salicylic acid and the three 
eresotinic acids i.e. 3$ 4? and 5 üiethylsalicylie 
acid# Wlstar albino rate of 170-250 gms. weight 
were used# The animais were paired for sex and 
weight; as before one animal was given the drug while 
the other was given the same volume of normal saline* 
For each pair the difference in rate of oxygen 
consumption# (AOp) expressed in mis,/hr* at 1*T*P, 
was determined*
-17.
The compoimds were injected intraperitoneally 
as Bolutiona of tlieir sodium salts (pH6*«9)«» Fresh 
solutions were made up every fortnight and were kept 
at 4^0 in the dark when not in use, 3?our doses# 
ranging from an arbitrary low dose to the maximum dose 
generally tolerated by the rats# were administered.
The observations were randomised# in respect 
of drug and dose# within a 4 x 4 Graeco-Latin square 
and twelve results of A 0^ (6 males# 6 females) y/ere 
obtained for each drug at each dose*
The combined action of salicylate and 
ortho-ereaotinate was studied on V/istar albino rats 
of 200-250 gma, weight, The rats were paired for 
sex and weight and male and female rats were used 
alternately, >Six rats (i.e. three pairs of the 
same sex) were used for each trial# one from each 
paire received normal saline while the other received 
an intraperitoneal injection of salicylate# or the 
equivalent dose of ortho-cresotinate# or a mixture 
of half of both, The difference in rates of oxygen 
consumption between the treated and eoiitrol rats of 
each pair was determined.
-18-
fime--eoncentrat:Ioii e^ cperimente # Wistar albino 
rats of iveights varying from 150 to 350 gms» were 
injected with the highest dose of the drug used 
previouslyg and killed by decapitation at varying 
times after the injection over a sizteen hour period, 
ihe doses used for injection ware 150 Bigrns. salicylate 
and 100 mgms. of the three ereeotinateB. The times 
of sampling w^ ere 15 minutes^ 30 minutes^ Ip 2p 4» 6,
8 and 16 hours &\nd determinations of the plasma 
Goi'ieentration from eight rats (4 malesp 4 females) 
were made for each drug at each time. The blood was 
collec t eel in heparlnised tube 63 and the plasma 
separated by centrifuging. Plasma concentrations 
of salicylate and the three eresotinates were 
determined by the method of Trinder (1954)g which was 
found to be applicable to the methyl substituted 
salicylic acids as well as to salicylic acid itself.
-19*
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The first e^ cpez'lmeuts were to determine 
which of eighteen compounds, related in their chemical 
Btruoture to salicylate$ could inoreaae the rate
of 03Eygen consumption of rats*
the difference in rate of oxygen 
conBumption of each pair of treated and control rats5 
was determined and the composite hypothesis that the 
mean difference was sero (H^ ) was tested against 
the single alternative that it differed from sero 
(H^)5 using the sequential test proposed by Wald 
(1947)» FormallyÇ in eaoh case5 where the mean A 0^ 
was ^  and the variance <r it was decided whether 
j ^ u  < Scr ( l . G #  11^) or whether |yx .| > 5 c r  (i.e. ) *
In these experiments S , which determines the critical
AOgÿ was assigned the value !• The maximum 
probability of a decision in favour of either 
hypothesis when in fact the other was true was chosen 
as 0*05« Z  ^ j  vfas calculated
after each trial g the trials were continued till the 
value of % fell outwith the region of indecision defined 
in the tables of Arnold (1951)* The number of trials 
reçiuired naturally varied from one teot to another.
Where was accepted the sign of the -mean A 0^ was 
forraally established from its 95?^ fiducial limits9 since 
in no instance did these limits include ^ero.
A histogram of the rates of oxygen 
consumption of the 164 control rats (weight range 
23O-.290 gma. ) shows a near normal distribution 
(fig* 1)* The mean rate of oxygen consumption was 
420*9 mls*/lu% and the standard deviation was 60.3.
A quality control chart^ in which each batch was four 
consecutive control results, confirmed that the 
experiments were in statistical control (fig. 2).
The results of these experiments are tabulated 
in Table XX. In eaoh case the 95^ fiducial limits of 
the mean A Og are given with the mean*
The main findings (detailed in Tables 
X¥II « XKXIXI) were as follows s 100 rngms. 2s3«- 
dlhydroxybensole acid, 100 mgms. phthallc acid and 
24 Tiigms. 6-methylsal 1 cy 11 o acid were without effect on 
the rate of oxygen consumption; 500 mgms. meta- and
'25,
niBifOgrams distrlbu'ülon of rate of oxygoii consiMption
of one hundred and sixty four control Wlstar albino 
rate.
Abscissaa oxygen consumption (mls./hr.).
Ord inat es frequenoy «
40
30
20
10
z L ' ^ > 0  35Ô 400 450 500 530 l!oO 6^^
"•26*
Control chaz't of the rates of ojcjgen consumption of 
one hundred and sixty four control Wistar alhino rats. 
Bach hatch coasioted of four consGOutive determinations. 
Ahoeiseaa batch number*
Ordinateg oxygen consumption (mis./hr.).
511.4
500
450
400
500 402010
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para-hydroxybensôiô aoiâg 3s4“ and 3s5-
dihydroxybon^oic aeid, 300 mgms. 2 g 4-dlhydi'o%yben0Olo 
aoidç 200 mgms. 2g6“Cliliyâroxybensoic aold, 100 rngme. 
5*”aminosalicylic aeid, salicyluric acid and ortho- 
aminobensoie acid and 50 ragms* salioylamide deo3?eased 
the rate of oxygen consumption5 120 mgme* salicylic
acid 9 105 xagms. para-oresotinic acid and 100 mgms. 
ortho- and meta-creeotinic acid markedly increased 
the rate of oxygen consumption.
Only four compounds were found to increase 
the metabolic rate of rats, fixese compounds 
were salicylic acid and the three cresotinic acids,
3g 4, and 5-methylsal.icyl 1 c acids. Qualitatively these 
acids were very similarg the maximum doses tolerated 
were of the same order and the toxic effects observed 
with higher doses such as hyperventilation and 
convulsions, were the same*
fhe next step was therefore to determine 
whether there were any differences in the potencies 
of these substances as metabolic stimulants in the 
intact rat.
-28-
Table II
Effect of salicylate and relat< on the
rates of oxygen consumption of Wiatar albino rata,
AOg is the difference in rates of oxygen consumption 
between paired treated and control rats (mis,/hr,). 
is the hypothesis that the mean A Og is zero, 
the alternative, n is the number of trials required 
for termination of the sequential test of against
Mean A 0,.
Oompoimd
Dos© 
mgme •
and its 95^ 
Fiducial Limits (a)
Hypothesis
accepted
Salicylic Acid 120 "03.5 ± 34.6 (10)
m-hydroxybenzoio
Acid
500 -173.0 4- 103.9 (6) %
p-hydroxybenzoio
Acid
500 —7B.1 ^ 42.1 (8)
2 §3-dihydroxy- 
benzoic Acid
100 -25.5 •î' 55.9 (12) %
234^dihydroxy- 
benzoic Acid
300 •*84*4 ^ 44.5 (7) %
2 g 5-dihydroxy- 
benzoic Acid
500 “332.9 ± 71.6 (6) %
2 g6-dihydroxy- 
benzoic Acid
200 «■121.5 + 71.0 (7)
^1
contd,
—2 9 "
Table II. (contd.).
I ■ i~ in i r — n r T ~ T  ■ i ^  •
Compound
Mean AOg
Dose and its 95^ Hypothesis
mgms, Fiducial Limits (n) accepted
3 s 4-dlbydroxy- 
benzoic Acid
500 -102,9 67.4 (10)
3 z5-dlhydroxy- 
benzoic Acid
500 -104#5 ± 69.9 (7) %
5-aminosalicylic
Acid
100 -95.1 '■r 55.4 (7) %
Salieylurio Acid 100 —46 • 9 4 * 29.9 (8)
Balicylamlde 50 -128,6 4h 46.8 (5) %
3-methylsallayl1c 
Acid
100 fl76.1 4* 76.7 (7) %
4-me thylsal1eylic 
Acid
100 4109,9 4* 53.6 (6)
5 -me t hy]. sail eyl i o 
Aeid
105 4-186.6 4- 62.9 (8) %
6-me thylsaliayli c  
Aeid
24 4-21,6 ± 61.7 (10) Ho
o-aminobenzoic
Acid
100 ®"6B*7 4 40.7 (7) IL,
Phthallc Aeid 100 -13.6 4- 48.9 (9)
*3 0 .
relative pateaeies of the sodium salts 
of these oresotinates as metabolic stiRmlan.ts were 
compared with sodium salicylate. Eats were 
injected intraperitoneally with four doaes of each 
drugp these doses ranged from an arbitrary low dose 
to the highest dose generally tolerated by the rat, 
The eoncentrations of the solutions need for 
injection were 5 gms,/lOO mis» for the three 
ore sot inat es and 6 gms./lOO ml,s. for salicylate» 
Table III gives the doses of each drug injected*
Table
Dose
Drug mgms •
Salicylic Acid 30  ^90^  120» 150
o-Oresotinic Acid
m‘-Oreeotinie Aeid) 25# 50» 75i? 100
n-Oresotlnio Acid
Initially, eight deterainatione (4 males,
4 females) of AO^ were Biade for each drug at each 
dose* Preliminary examination of the results showed
31
aiï apparently linear relationship "between A Op and 
dose within the dose rang© 50*«100 mgms. for the three 
oreeotinates and within the doee range JO^ -ISO mgrae, 
for salicylate (Fig, 5)* Poraial confirmation of 
this hypothesis Involved further determinations of 
AOg at doses of 62.5 and 87.5 mgma, for ortho-, meta- 
and para*-0reBotinatGp and at 60 and 135 mgias, for 
salicylate,
Consideration of all the results (Fig, 4) 
suggested that there was indeed a linear relationship 
between A Op and doe© between the doses 62,5 and 
100 mgrnsm of the three oreeotinates and 90 and 
150 mgïiïBé salicylate, therefoi'o further observations 
were made within these dose ranges.
Twelve doterminations of AOp were 
finally made for each drug at each of the doses 
given in Table IV and these results were used 
for the formal analysis. The mean A Op for each 
drug at eaoh dose is given in Table V, Fuller 
details of the results are presented in Tables
x m v  - XIXVII,
I)osG-5?esponse corvee of salloylate ( o ), ortho-
oresotisiatG ( o ) » meta-creeeotinate (A---) ^ and para-
oresotinate C + ) on the rate of oxygen eonsnmption
of Wietar albino rats#
Abaci sa a s do a© (lagms # ) #
Ordinate t AOg (mis,/hr. ).
AOg - the differenoe In the rate of oxygen 
conanmption between paired treated and control rate# 
Each point is the mean of eight determinations of AO
+ 150
+ ICO
A
+ 50
150ICO50
■33-
Dose-reopomae emrvea of ealiojlate ( O ), ortho-» 
cro sot inat e ( a ) @ yaeta-creBotinate — ) and para- 
orosotInate (+ ) on the OKjgon coneimption of Wistar 
albino rate*
Absciseag close (mgrna*)*
Ordinate g A 0^ (mis./hr.).
A 02 he difference in the rate of oxygen eonaumption
between paired treated and control ratso
Each point is the mean of eight determinations of ^Op.
+200
+ 1 5 0
+ 100
4 5 0
;oo so
-34-
IV.
Doee
D m ig  m gm B  »
Saliojlic AcM 90  ^120, 135, 150
o-OreBotlmlG Aeid)
m->Oresotlnic Aeid) 62.5, 75» 87.5, 100
)
p-^Gresotinic Aeid)
Before proceeding to the analyses of 
variance of these data, homoeoedasticity was eatabllshed 
by Bartlett's test; 0.50 > P )0.10.
In each ease, within the dose range finally 
selectedp the dose^response curves fitted regression 
equations of the form y^  where y^  was
A Op (nils./hr. ) and was the dose (irigma.) (Pig. 5). 
Thisp therefore, made possible a comparative slope- 
ratio aesay*% in which the potency ratios were obtained 
from the regression coefficients. Thus, where any tv;o 
of the regression equations were y, - a, 4- z, and 
y^ - P, ~ b,/b^ gave , the potency
ratio of b^  with respect to b^.
Sable ?.
The mean diffex^eneee in rates of oxygen o<
Wta r;e siQi!g t^gMg,:g; . i4W!!w :jfc : '^ tiWQBt-ateKs!wt»mg«wc>»paatr=a«7rq«jsa?K!.^:^
between pa treated and rata
doses of Ballcylate and the three creeptinatee
f  JW ' I  I  irm & i     v u  v n ■ u . i i  . ' g jA i '. u i u -M ►■n * i i
Differences in rates of oxygen consmption 
(AOg) are expressed in mis ./hr.
Dose Salicylic 
(mgms.) loid
Ortho- Meta- Dara-
Gresotinio Gresotinic Cresotinie 
Acid Acid Aeid
62.5
75.0 
87.5
90.0 
100.0 
120.0
155.0
150.0
+34.7
52.7
'•> g
+105.2
+82.2
+127.4
+134.7
+177.8
+19.8
+70.0
+91.7
+97.8
+51.9
+57.9
+89.4
+114.4
Boee^response oiirTes of saliojlete ( O ortho««*
e re g o tiiia te  ( a  ineta-om^eootlmate (a  ) and p a ra -
creeotinate ( + ) on the rata of o^ qrgem eoasMmptlon 
of Wietar alMsio rats.
Ahsoiaaag dose (mgma.)*
Ordinates AOg (mla./hr". ) o
A Og ^ the different© in the rate of oxygen oonemptioii 
between paired treated and oontrol rata#
Eaoh point ie the mean of twelve determinations of AO^-
-t-150
+100
+ 50
150125JOG7550
Variance v/ae divided into that due to 
(i) regression, (11) deviation from regroBsions 
(ill) between doses and (iv) residual.
The I'cqnirements for a valid slope-ratio 
assay are that there must be linearity i.e. the 
regression of response on doee muet be linear for 
each drug and that the intercepte made on the Y axis 
by the four regression lines must be the same, within 
sampling error (Bliss, 1946). The second point in 
analogous to parallelism in parallel line assays since 
it derives from the very existence of a potency ratio. 
These conditions were met in the analyses of variance 
summarised in Tables VI and VII. Puller details of 
the analyses can be found in the ^^ Statistioal Methods** 
section# Application of the P-test to the between 
intercepts mean squax^ e, the deviation from regression 
mean square and the residual mean square showed that 
there was neither significant deviation from linearity 
nor difference in intercept*
The potency x^ atlos of the ore sot inat es 
relative to salicylate, and the 95/^  confidence limits, 
presented in Table VIII were then calculated as 
described in the **Statistical Methods'’ section. To
J0*5*
Ttih lQ VI.
.Analyses of variano© of A 0^ and the smlon equatione
of A Or, on close for ealie.ylate and the three oresotlimteB.
AO^ iB the différence in rate of oxygen, oonsumptioa 
of paired treated and control rata, 
y - AOg (ails./hr*)9 x doee (liigme.)*
Balioyllc Aoid* Boso range 90-150 aigaie* 
degression equations y 51.95x - 32.20
Source of variance Sum of squares d.f. Mean squares
Between doses.
Due to regression 28,792.43 1 28,792.43
Deviation from
regression 6,914.41 2 ' 3,457«21
Within dose 192,202.16 44 4,368.23
Total 227,909.00 47
Q-OresQtinio Aoid* Dose range 62.5 - 100 mgms. 
Régression equations j - 146.95% - 60.54
Source of variance Sum of squares d.f# Mean squares
Between doses.
Due to regression 
Deviation from
51,823.39 1 51,823.39
regression 3,297.56 2 1,648.78
V/ithin dose 207,559.04 44 4,717.25
Total , 262,679.99
contd.
'^39'**
47
gable VI. (oontd.)
m-OresqtlnlG Aoid» Bose range 62.5 •» 100 mgms.
Regression equations j - 127.74% - 96.24.
BouroQ of varianoe Sum of squares d.f. :ieaîi squares
Between doses»
Due to regreaaiOB 39,160.49 1 59,160.49
Deviation from 
regression 5,945.44 £ 2,872.72
Within dose 117,908.08 44 2,679.73
Total 163,014.00 47
p-Oresotinie Aeid» Bobs range 62.5 - 100 jagms.
Regression equations y ™ 109»39% 63*60
Bouroe of variance Sum of squares d.f. :lean squares
Between doses.
Due to regression 28,717.50 1 28,717.50
Deviation from 
regression 1,704.44 2 852.22
Within close 186,808.75 44 4,247.47
Total 217,510.68 47
’40’
Table VII
Blope ratio assay of ealicylate and the cresotinatesî
general analysis of variance»
m m a/m Ê Ê Ê tm m m Ê m m È m m m m m xjriiA L  ‘i i .'i n t im  ■ m .j» t : - ,s J u ^ m .. ju y m rg E g g g;* s L?^ '’j c a w . '' ta»gr i
Source of variance
Sum of 
equaree d.f# Mean squares
Duo to linear 
regressions
148,493.61 4 37,123.45
Deviation from 
regressions
17,861.85 a 2,232.73
Between intoroepta 3,672.35 3 1,224.12
Residual 704,831.22 176 4,004.72
-41
ïïable nil.
Moxar potenc.v ratio g of the three ore sot inat e 3 
relative to saMoylate as metaboXio stimulants
in the intact rat*
Potency 95^ Oonfidonce 
%'ug Ratio 1,1ml ta
4 2 '
o-OresotlnlG Add 2#.61 2.50-2
m-Oresotinic Aoid 1.7B 1*69 - 1.87
p-Greeotinio Acid 1.89 1*79 “ 1.99
allow for chemical equivalence of the drugs these 
potency ratios were calculated, in molar units.
Significant differences in potency were 
foundp In comparing the three oresotinatos with 
salicylate, as metabolic stimulants in the intact 
rat.
In these experiments the rats were of a 
lower weight range than in the previous experiments.
The histogram of 252 control results of the 
rates of oxygen consumption of rats of this weight 
range {170-250 gms.) showed a near normal 
distribution (Fig. 6) and the quality control chart 
in which each batch was four consecutive control 
results showed that the experiment was in statistical 
control (Rig# 7). The mean rate of oxygen consumption 
was 389*2 mls./hr. and the standard deviation was 
48.5.
She distributions of the rates of oxygen 
consumption for the "Irvvo series of experiments were 
similar. In the first series the weight range was 
230-290 gme. and the mean rate of oxygen consumption 
vms 420.9 mis./hr. (S«3). 60.3)5 while in the dose-
•43’
Fig. 6.
Histograms distribution of rate of oxjgen consumption 
of two hundred and fifty two control Wietar albino 
rate*
Ibsciesas oxygen consumption (mls*/hr*)*
Ordinate z frequency*
120
100
ZT5 525 4Z5 475 ? l5  5T5
/ •44"
Geatrol ehart of the rates of o%yg<m ooaeimptloa 
of t^o himared m a  fifty W o  oomtrol Matar elbiao 
3^ RtOa EaOh hatch (M*R83Ls)l&ea of foar ooasooutlve 
<%<3Mb43ür:adL23w&ib3L<>%i(%<k 
Abaoleea: batch aumber#
Ordiaateg o%ygoa oonsomixtloa (ml8,/hr» j »
450
400
589.2
550
541.7
311.1^
300
responee experiiiienuB the weight range was 170«*250 gms. 
and the mean rate of ciggem ooneumption was 
589*2 ml8*/hr@ (B*.D* 4B*5)* Although these 
figures imply correlation between body weight and 
rate of oxygen consumption^ body weight did not 
perceptibly influence the valties of A Og. For 
example, using the -Welve results of A Og obtained 
after injection of 135 mgms* salicylate no 
correlation was found hetween body weight and A Op.
(:e ™ 0.02, P>0.50). This implies that other 
factors overshadow and obscure any possible 
relationship between AO2 and body weight.
One possible explanation of the greater 
potencies of the cresotinates as metabolic 
stimulants was that they differed from salicylate in 
their primary action, fhis possibility was next 
investigated.
>46'
The nature of the eombined action of 
salicylate and ortho-oreaotinate was determined as 
described by d-adclum (19^^) « Such experiments might 
point to a difference in the primary action of the 
two drugs, which in tux*n might explain the greater 
potencies of the cresotinates, partieiflarly the 
ortho-cresotinate•
fhe effects on the rate of oxygen 
consumption of a selected cloaa of salicylate, an 
ecpaipotoïit dose of ortho-oresotlnate^ and a mixture 
of half of each dose of the two drugs, were oompmred. 
A 02  ^the difference In rates of oxygen consumption 
for paired, treated and control rate was determined 
for 150 mgme. salicylate (S), 70 lagme. ortho- 
cresotinate (0) and a mixture of 75 mgms. salicylate 
and 35 mgms. oz'tho-orosotlnate (BO)* The rcesults 
were put simultaneously to three seq.uential tests; 
these tests ware to determine whether or not the 
effect on the mean A Op of the mlxtux’e of 75 mgrns* 
salicylate and 33 rngms. ortho-cresotinate was 
distinguishable fz'om the effect of twice the dose 
of either of the two drugs administered separately. 
fhe differences tested were therefore A Op (B) "»
«*47""
AOgtO), AOpCB) - AOpCSO), AOp(O) - A0g(80}.
In each case, the hypothesis (11^ ) that the mean 
difference was zero was tested against the single 
alternative (H^ ) that it differed from ^ero. Formally,
in each ca,se» it was decided whethez" I
or H, :
A X  S tr
X  where was the mean difference
cr^ was its variance ; the value of S wae taken 
as 0*7# The maximum prohahillty of accepting a wrong 
decision was, In each case, Q#05*
In these experiments, controls could have 
been omitted and the direct differences in rates of 
oxygen consumption of rats receiving the three 
treatments considered* For this puz^ poae, the rats 
would have been used in triplets, which in terms of 
practical convenience offered no advantage over working 
with A Oo#
The results are ezimmarieed in fable 131* 
fuller details are presented in fables X3ŒVIII - 3LÏJÏIÏ. 
In every case the hypothesis E was accepted* Ihus, 
admini strati on of a mixture of salicylate and ortho*** 
oresotlnate gave a response which was indistinguishable 
from an additive effect, azid therefore no difference 
in the primary actions of the two drugs was established
4B-
by this experiment*
The other poaelbility considered was that 
the %'elatlve potencies of the crosotlnateB might be 
dependent on variation in rates of degradation and 
excretion; the present investigation was concluded 
with an examination of this problem.
—49*^
Table IX
Combined action of ealicylate and oartlio^ c^a^ eBotinate*
Eesults of the seciuantial tests of the hypothesis 
that the mean difference in AOg of x^ ats treated 
with 150 mgms# salicylate (S), 70 mgras. ortho-* 
cresotiBate (0) and a mixture of 75 mgnis* salicylate 
and 35 mgma. ortho-oresotinate (SO) were equal* 
Formally where each me&m difference was and 
its varianee the hypothesis |y^ | < 0*7 <r 
was tested against |/^ |^  0.7 e- ; the probability 
of accepting the wrong hypothesis was 0.05*
Difference
lo. of
trials hy%)0 thesis 
required accepted
Mean difference 95# 
fiducial limits of the
tested mean
(s) - (0 ) 14 Eq 41.6438.5
(s) “ (so) 14 46 0 O44I* 6
(0) » (SO) 44 * 4,443 * 5
—50""
The posaibility that differences in rates 
of degradation and excretion between salicylate and 
the three cresotinates might aceomit for the 
differences in potencies has been put forward, It 
was examined by comparing the rates of disappearance 
of the drugs from the blood after single intraperitoneal 
injections^, Eats wore given the previous maximura 
dose of the drugs, and aaorifieed at varying times 
after the injection* Determinations of the plasma 
drug concentration were made on eight animals for 
each drug at each time* The method for estimating 
salicylate, described by Trinder (1954), was 
applicable to the three cresotinatesa In each case, 
Beer*8 Law was obeyed over the range 100*«600y^ g. 
per ml* (fig* 8)*
The mean plasma concentrât ions for each 
drug at each time are given in Table %. Fuller details 
are presented in Tables IXI? «>• XLVIIo Blume and 
Plum (1935) have shown that, in rabbits, salioyla,te ■ 
appears in the blood 2& minutes after eii 
Intraperitoneal injection and after reaching a maximum 
falls g*radually for six hours* Similarly, in the 
present results the time-conoentration curves showed
•51
COrinder’s method for the estimation of salicylate 
in biological fluidse standard graphs for 
salicylate ( (> ), ortho-oresotinate (0)5 meta- 
cresotinate ( A ) and para-^cresotinate ( i- ) * 
Abscissas concentration of solution (^gme*/ce,) 
Ordinates optical density*
1*0
o $
0-6
04
0 2
I 0
0-8
0-6
02
too 200 300 400 500 (00 200 300 400 500
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fable X.
fhe mean drug plasBia concentrations in Wistar albino 
rate at the Mdnea aft^ injecrblon of sal
and the cresotinatee*
Plasma eoncentrations are expressed in
Ortho* Meta* Para-
Siae
( î l î * S .  )
Salicylic
A d a
Î cresotlmlo 
A dd
crcsotinie
A d d
G s e s o t i a i e
A d d
.25 7.95 6.89 6.41 6.09
.50 8.11 6.71 7.05 6 . 2 1
1.0 7.57 6.61 5.72 6.15
2.0 6.43 6.60 5.58 5.67
4.0 5.98 5.12 4.75 5.20
6.0 5.19 4.82 4.60 4.37
8.0 4.53 4.16 4.14 4.15
16.0 3.02 2.76 2.20 2.59
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in all oases an apparently escponential decline (Pig* 9)* 
transformation of the concentrations to a logarithmic 
scale conferred linearity to these data (Pig* 10)*
After this transformation the curves fitted regreaeion 
équations of the form Jj - aj -h hj itj where Yj was 
the log of the plasma drug concentration expressed 
in milli^ -equivaleiits per litre and Xj was the time 
after injection in hours*
The hoaosoedaaticity of the transformed 
data was confirmed by Bartlett’s test which gave 
0*50 > P > 0*10; analyses of variance failed to show 
a significant deviation from linear regression for 
any of the drugs (Table XI)* Formal comparisons 
of these regression lines were then undertaken*
Any linear regression is fully defined 
in terme of two parameters § elevation and gradient*
In the present experirâont the elevations were mainly 
dependent on the initial dose of the drug injected; 
the gradients 9 however^ were characteristic of each 
tIme-c oneentrat ion relationship and any differences 
in the rates of degradation or excx^etlon would appear 
as differences in g3?adient.
An analysis of covariance which is
•54<
Plgq 9.
i’ime-conoentration curves of salicylate ( o ) ^ ortho- 
eresotiuate ( O )p meta-ores o t inat e (A) a:aà para- 
cresotinate (t )«
Abscissas time after injection (hours)*
Ordinates drug plasma concentration (moEc./h#),
Each point is the mean of eight determinations «
7 0
£-0
4 0 -
•O-
14 16K) 1264 2 62 10 12 14 16 46 8
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Pig. 10.
fli-a transformed tIme-oonoentration eurvoe of 
aalloylate (o )  ^ortho-oreaotinate (a )  ^meta- 
ereBotinate ( A ) and para-creaotlnate (+ )« 
Ahsciaaaâ time after in;) e et ion (honra) <,
03?dinates log drug plasma, concentration (m*Eti«/ïî*) 
Each point 1 b  the mean of eight cleterminât!one «
1 1 1 t 1 1 1 1
^ t t ^ n
... 1 1 1 1 1 1 1 1
A .
- - - - - - - 1- - - - - - - 1- - - - - - - 1- - - - - - - 1- - - - - - - 1- - - - - - 1_ _ _ _ _ _ _ 1- - - - - - - _ _ _ _ _ _ _ _ _ _ — 1- - - - - - - 1— 1— 1— 1— 1—  1 I- - - - - - - - - -
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eummarieed In fable XII, oomflrmed that there was no 
significant difference between the four regression 
coefficients* Application of P-tests to the common 
line mean square g the regression coefficient mean 
square and the within sample mean square9 gave P>0*50* 
This established that the four regression lines did 
not come from different populations*
There was thus no evidence for any difference 
in the rates of degradation or excretion*
In the preceding experiment9 the dose 
Eidministared was not based on the animal’s body 
weighty instead9 the distribution of body weights 
was randomised* O.Maere was^ of course9 a correlation 
between the rat’s body weight and the plasma 
concentration attained at a given time after a single 
Injection* This was shovm by an analysis of 
covariance, in which oovarianoe was divided into 
"within** and "between" classes# In this analysis 
the four classes were the four drugs at the first 
time i*e* 15 minutes ; within each class9 there was a 
significant correlation between body weight and plasma 
drug 0 one ont rat i on 9 ? < 0.001 (Table XIII).
Mew regression equations vmre calculated
gal)le XII.
$h@ disappGaraixoo from the "blood of salicylate and
V  « .k  '. I ' A !, WLü'AALi',-J  ! A' 1-, Ys» »\ 1 * '■*'-*-*■ ^*~i‘ » », • «IV, V,' t;
the ci*esotinateB. The regresslomo of log plasma
<gi:te .U J = a f3 B g :.J V .j.B^ :v ::a ;i.J J J t y a s .it i M,'w .:~ itr jia E X .‘^ ! U ; -jT J 3ae ^ T r a«su!i t J ;iaLÿits:T»^Æi^ 0 1 t i . j j ^ ^ t : . j Æ 'Æa.'.,-;» :i •*>rTTifs » < s fc s a = t? c a s s s 3 g i :â ï ‘j f a .;. jE i g'.;.^ ^
drug coB.centratione on time after injections
IK t:« L ^ .L .:K ih E K U a =, : ^ : J  ■- '.i a i . j i A - i ^ ^ 'K a - t . j iSa n  » ..'.  ;j i  « . i .;.i Æ a R ^ ; a att.^» j» iJf.u r j w j n s r...r : a : t i - iU A . J.l;JS',J tB -a r .J T r ::T T iT a = r3 t..A : - 4 . ; - f i j  iâ ;
Source of 
variance
Deviation from Regression 
Rég'reselon Sum of Mean
Qoefflolont squares d*f* squares
Salicylio
Acid
-0.0268 ■ 0.3342 62 0.00539
o-Oresotlnlc
Acid
-0.0261 0.2674 62 0.00431
Bi-CrGaotinlo
Acid
-0.0294 0.3299 62 0.00532
p-Gresotinio
Acid
-0.0253 0.3787 62 0.00611
Within 1,3102 248 0.00528
liegrcession
Ooefflcieat
0.0151 3 0.00503
CoHimon hine -0.0269 1.3253 251 0.00528
Elévation 0.2764 3 0.092
Total 1.6017 254 0.00631
- 59.
0
M
M
Q)
H
çQ
m
m
m
G)
g«M.p
O
m
0
@{
'0
0#
.pg
H l
O
'H
H
m
m
O
*H
-S e
r4
m «A 0
O
O CM 'f4
o * D- 4 4
A « *H* 44 O  d
G ^ m
o 0 Il *H
•H 4^  d m
U
O G <^St
0 H oT3 O 0
•H
'H 4^1 Pi
S
4"îc3
m
m
-p
0
lA
f™î
_p
ej
03
m
I
0
0  
44
1
0F-î
e
03
0
803C3
r-î0
144
03
&{
44
m
o
o
4-1
O
4-1 $1 O O 
"H0 .p
O  (33 F"î "H 
0ô cd m >
CQ
&
m
mcd
M
0
d
m
1
0
m
î“îï>o 
•  o
o  e
« V
" 94
U
O
0
CO
M3-P o lA D-
îs:î H  
m m
VD H
«
•rî 8 O O
O 0 « 8
ri fi
44 N)
O
n
4-J 0 H
0) A
o
LA lA
m s>-
4*1 4^ i > « 4
O  O * CM CO
0 iA o
VO O cm
0  0 r" l H 8
CQ U 8
P4
0
44 m SA £ > SA CM O mo A CO l> - r 4 LA > -
, ^3 lA * v o # CM •g 0 (S fK CM *1 CD
ÏA H o ÎA
m  m VD CD
*
44 CA CO H• CM ÎA
m
0
m
m
üS
r”î
O
H
•P*rl
H
m
OCi
60-
in whioh the log plasma drug concentration was linearly 
related to both body weight and time i *e * regression 
equations of the form Y a t b, -f Z;; where Y 
was the log of the coneenti*ation in millr-equivalents 
per litre g %, was the weight in grams g and x ^ was 
the time in hours, lor each drug an analysis of 
mxO,tiple correlation showed that there was a significant 
component of variance due to weight. The results of 
the 1—tests gave P < 0.001 (Table XIV).
Inclusion of body weight in the regression 
equation therefore altered the regression coefficients 
of log concentration on time slightly^ but not 
signifieantly. Table XV shows the values of these 
regression coefficienta.3 b v^ as the regression coefficient 
when weight was not included^ b^ was the value when 
weight was included. For each compound the value b 
was tested against an arbitrary value (b ) by a 
t^test described by Fisher (1954)• lo significant 
differencea were found,
This confirms the successful randomisation of 
the rant’s body weight and justifies the practice of fixed 
doses not based on body weight.
It is concluded that there is no gross 
difference in the rates of degradation or excretion of
the drugs.
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TehXe XV.
slen’cs or xoe: nraema 
oonoentratioii on time after injection for 
salicylate and the creBotlnatesg _ t^teats 
of the di^erenees^ J:^ t%veen these values ^
b is value when rat body weight was not included 
h^ is value when weight was included.
Drug h t and P
Salicylic Acid 0.0268 0.0266 0.119 P>0.50
o-Oresotinic Acid 0.0261 0.0245 0.98» P >0.10
Bi-Oresotinlc Acid 0.0294 0.0306 0.66, P > 0.50
P"Greaotinie Acid 0.0253 0.021? 1.82, p >0.05
BlBCUseiora.
Before cliscueeing the reaulte of this 
investigation in detail, the experimental oonditionis 
and theoretical background will be briefly considered.
In aoGordanoG with the practice in this 
laboratox^ y (Cameron, 1957), the variability of 
biological materiel, was accepted; variations in 
exercise, feeding etc. were asBurned to be randomly 
distributed. The animals were, however, paired 
for sex and weight, and all the animals were chosen 
within an arbitrary weight rmige. The near normal 
distribution of the rates of oxygen consumption (Figs.
1 and 6) of the control rats and the quality control 
charts (Figs.* 2 and 7) showed that the expexdments 
were in statistical control.
The room temperature was, as far as possible, 
maintained at 18"20^0, because variations in the ambient 
temperatui'G could affect the rate of oxygen consumption
•64'
of the rats. In the preliminary experiments, for a 
few days at the height of Bummer, the room temperature 
rose to 23-25 0 and the hatch mean oxygen consumption 
fell helow the inner control line (Fig* 2).
The Bequential test devised by Wald 
(1947) was a most appropriate method of sta,tistioal 
inference for many of the experiments. The theory 
of this sequential "t-test" has only been developed 
in respect of two exhaustive and mutually exclusive 
composite hypotheses; the sample sise is, of course, 
not fixed in advance but is determined by the nature 
of the data themselves, in relation to the degree of 
discrimination %*equired, and the maximum acceptable 
probability of a wrong decision*
There are certain advantages, apart from 
economy of observâtiono required, in such a tost.
The parameter 6 , which determines the critical limits 
of the test can be freely chosen to fit the 
requirements of a particular experiment* Thus, in 
the first series of the present experiments, b was 
taken as 1, so that the test would not distinguish 
between differences in the mean rates of oxygen 
consumption less than one standard deviation of the
—65'^
mean difference. Ira the combinecl action experiments, 
where greater discrimination was deeirahle, S v/as 
taken as 0.7*
There are two types of statistical error 
possible in such a test. We may reject II when 
it is in fact true Type I error, or wo may accept 
when it is false Type II error* The maximum 
probabilities of these errors have been designated 
oC and ^ . This test, unlike Student’s claasieal 
t"tGst, takes account of both types of statistical 
error, so that a negative conclueion (H^ ) may be 
positively asserted with as much oonfidenoG as the 
alternative (H-|). A further advantage of Wald’s 
test is the wide range of choice of values for 
oC and y3 * Throughout this investigation the value 
of 0.05 was chosen for oi and yd ,
Thus, by chooaing suitable values of the 
parameters of this test, it Is possible to set up 
realistic and appropriate tests for a very wide range 
of experimental situations*
The doBc-response curves of the three 
cresotinates and salicylate exhibited a linear 
relationship between doae and diffcadence in rate of
™66«»
QKjgùn consumption between paired, treated and control 
rate (AOp). There was, therefore, no need to 
traneform dose to a logarithmic scale. The present 
dose-responBe relatioxishlp is consistent with the 
results of Alexander and Johnson (1956) on human 
subjects and of Eeid (1957) on rabbits* This 
present assay was therefore a comparative slope^ratio 
assay and differed from the ooDmon parallel line 
assays in that the potency ratios depended on , 
the gradients of the lines*
The first recorded use of a slope-ratlo 
assay appears to be that of Birch and Harris (1934), 
although their discussion did not explicitly recognise 
the nature of the analysis. They found that the 
duration of cure of bradycardia in vitamin 
deficient rats was directly proportional to the dose 
of vitamin given, and proposed to estimate the 
potency of a, test preparation by adjusting the dose 
scale until its response curve corresponded to that 
of the standard. Oinee then there Imve been a few 
other cases cited in the literature, concerning work 
on whole animals, in which the effect metameter has shown 
a linear relationship to dose e.g. Levin and Tyndale
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(1937) on the quantitative assay of follicle 
stimulating substance; Bergmami amcl Turner (1939) 
studying the guinea pig and chick thyroid in the assay 
of thyrotropic hormone ; O’Brien and Morgareidge (1939) 
on the effect of phosphorus on the biological 
estimation of vitamin D activity in x^ ate with z'ickets; 
Emmons (1939) on the effect of an.drogene on the eomb 
length of capons; and Bates, Riddle and Miller, (1940) 
on the assay of adrenotropic extracts on two day old 
chicks•
In recent years, increased interest in 
microbiological assays, based on linear dose-response 
relationships, has enoouraged the derivation of 
analyses of a epeoial case of slope-ratio assay, where 
both test and standard active substance are the 
same and where linearity extends down to a common 
positive response at sero dose (Wood, 1946). Various 
statistical methods of analysing such data have 
been developed, using the method of maximum likelihood 
and fitting the data to multiple regression equations 
(Wood and 3Pimi.ey, 1945).
The assay of the four metabolic stimulants 
described in the present investigation was novel; 
because (i) the comiion intercept on the % axis was
— Orie-a
negative g i.e. the dose-^reeponse curves must approach 
the X axlB asyiaptotically (vide Pig. 4)9 (11) it was 
a comparative assay, and therefore better not treated 
in terme of multiple régression.
A procedure derived by Bilvey (1958), by 
the method of mmclmum likelihood, met the present 
requirements. fhe main features of this analysis 
were as f oil owe s-* if m drugs were given to n 
individuals at p doses, drug c being applied at 
doses then the response of the n
individuals vfho received dose of drug t were
denoted by ... c^jn * !:î!he equation
of the line for drug i was y^  %= 4- b^% Before
estimating poteney, compliance with the tvm 
fundamente^l conditions, linear dose-response 
relations and common intercepts, was first tested 
by a general analysis of vai'lanee. In testing for 
a common intercept, since the doses used were not 
the same for the four drugs, a weighted variance was 
used. It was shown that, in the present assay, 
the variability of the a I *s was due simply to the 
inherent variability of the experimental Biaterial and 
thus the regression equation of drug L was of the form
■69^
y «s (< f PiX where ai did xaot depend on the àrug^
TkilB fact %^/as used to calculate for each drug an 
estimate of better than b i and from these batter 
estimates of the potencies and the 95^ confidence 
limits were calculated® (Dhe theory of this step 
was based on the assumption that the distribution 
of response to a particular dose of a particular drug 
was normal, and that the variance of this distribution 
depended neither on dose nor drug. The estimate 
of co3:ifidenoe limits was only valid when the standard 
deviation of hi was small relative to (Bilvey,
19!%3).
The theory of the combined a^ etion experiments 
is well known and is amply discussed by Gaddum (1953).
The rates of degradation and excretion were 
compared from the time--concentration experiments «
In every case, transformation of the drug plasBia 
concentration to a logarithmic scale gave a linear 
relation with time, oonsistent with exponential 
time-coneentration curves. Theoretically, this 
indicated thsit the type of curve obtained was similar to 
that exemplified olaeeieally by Newton*a law of Cooling.
E \
KxproBBing t h ia  in the form o f mi e q u a tio n
d e /d t  ko 1,00  th e  r a te  o f  f a l l  i s  o m w e n tra t lorn g
G g with time 9 tg was proportional to the oojioeatration. 
By integrating^ log o -ICt <0 l^iu the log of the 
eoHoeiitratloB la Intlireetly proportional to time*? 
where E and Cl are constante of the linear equatioso 
The tlme-ooneentratlom ourvea thus fitted regreaeicm 
equation of the form Ij ^ hj ivhere f j wao the 
log of the plasma coimentratlom and Xj wsa the time 
after injection# fhe only parameter Hooooaory to 
define the rate of dlaeppeanxiioa of the drug from 
the blood was therefore the régression coeffleientg 
hj; the intercepts on the 1 axis were dépendent 
OH the Initial dose injected#
D ro d le , Soheroian, le v y ,  A x e lro d , H o lla n d e r  
and S te e le  (1949 ) in  t h e i r  s tu d io s  cm th e  d e g ra d a tio n  
o f  a n t ip y r in a  in  th e  measurement o f t o t a l  body w a te r  
a M  King and Harvey (19 53 ) s tu d y in g  th e  a b s o rp tio n  
and e x o re tio n  o f  d In ltro -^ o rtlio -^ c re s o l lun/e used a  
s im i la r  tra n s fo rm a tio n  and Gaidum (1 9 4 4 ) has s ta te d  
th a tp  w ith  th e  e x c e p tio n  o f a lc o h o l, most drugs show 
t h is  e x p o n e n tia l typ e  o f  decay#
The e f f e c t  o f body w e igh t in  r e la t io n  to
i a  IT S
the time‘-concentrât ion expérimenta ïiierits some 
diactission since it is a common practice to adopt 
a system of dosage in units of drug per unit body 
weight ; this assumes, between these factors, an 
explicit relationship)@ the existence of which is not 
self evident* An analysis of covariance established 
that the drug plasma concentrs>tion of each drug was 
dependent on the rat * s body weight. Including body 
weight in the regression analysis, new regression 
coefficients due to time were calculated^ the 
regreesion coefficients of log concentration on time 
were not altered significantly by this inclusion. In 
the present eireumetances it would have been pointless 
to make any allowance, in the dose injected, for body 
weight, when randomisation was clearly sufficient to 
control this factor.
Having considered the experimental 
conditions and theoretical background, the results 
of this Investigation and their significance can now be 
discussed in more detail*
The compounds tested in the first experiments
fall Imto th re e  groupas
C l) In e r te  fh e  drugs whioh a t  th e  doae a d m in is te red  
did not alter the rate of oxygeai oonemDptlou of rate
were 2 i5^ «dihydroxyboii^ olo aold, phthalio acid ami
6 - -a e th y ls a l ia y l io  aeid#
Although Brody (1 9 5 6 ) found th a t  2z3^ 
cIlhydroxybeBsolo a c id  v/as am in l i ib i t o r  o f  0 3 ;ld a tlv e  
p h o s p h o ry la tio n  o f r a t  m ltoo îiondriu  he d id  no t 
im re e tig a to  I t s  e f f e c t  on th e  r a te  o f  oxygen uptake#
In keep ing  w ith  th e  p reeent r é s u l t é , Meade (1954) 
found th a t  the em ail dose o f  50 mgma# 
dlhydroxyheim ole  a c id  f a i le d  to  in e ro a s e  the  m e ta b o lle  
r a te  *
6-==i-aetliyloalioylic mold was much more to x ic  
thon  miy o f the  o th e r eompomids which were to u ted  b u t , 
i n  doses a t  which i t  was to le r a t e d ,  i t  d id  n o t 
a l t e r  th e  m etab o lio  ra te #
(2 )  Drugs w hieli deer eased the  r a te  o f  oxygen 
eonsumptlon o f r a te  (^ 'm otabolle dep^zessanto" ) # J:kmy 
o f  these eomporaido were to le r a te d  a t  h ig h  doses#
At eueh doses mota- o M  paraW*ydroxybemsolo acid,
2 s4<-9 2 §5-9 3 ^ 4 - and 3 s g^dlhydroxyben^ole a c id
depressed the  ra te  o f  oxygen oonsumptlon o f ra ta #
5-amino a al1ey11o acid, salicylamide, salicyluric acid 
and 0‘-aminobeuî30ic acid were also metabolic depressants 
when given in doses similar to salicylic acid.
Meade (1954) used very much smaller doses 
of the hydro3cyben^olc acids ^md found that only 
the meta substituted derivative was a metabolic 
depressant® 50 mgms. salicylate was a metabolic 
stimulant, and the same dose of para^hydi’oxybenKoate, 
2s4*“ÿ 2:5-, 2i6-, 3 s 4- and 3s5*-dihydroxyben2;oate ?/ere 
inactive* In a preliminary report Hall, Torn!oh 
and Woollott (1954) stated that meta- and para- 
hydroxybenjsoic acid, 2s5- and 2s6-dihydz^oxybengolc 
acid and aalioylamide had no effect on the rate of 
oxygen consumption of rats or mice but they did not 
state the doses used*
Gentisic acid i.e. 2 3 5-dihydroxybensoic 
acid, and salicyluric acid have been isolated in the 
urine as metabolites of salicylic acid (Kapp and 
Goburn, 1942). Thus, in the body, some salicylic acid 
is converted from a metabolic stimulant to a depressant, 
which suggests that these two acids, salioylurio and 
gentisiCp are true detoxication products in respect 
of their metabolic stimulant action*
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It was already îmown that the 
entituberoulous drug@ para-aminosalicylic aeid
4“«aminosalicylic acid, depressed the rate of 
oxygen coiiaumptlon in man {MacGregor and Bomner,
1954) and, for this reason, the effect of 5-amlno- 
salicylic acid on the metabolic rate was investigated 
The S^aminosalioyllo aeid was also a metabolic 
depressant.
(3) Drugs which Increased the rate of 03Eygen 
consumption of rats {"metabolic stimulants"). The
only compounds which increased the aietabolie rate 
of rats were salicylic aeid and the ortho, me ta-, and 
para*-cresotimc acids*
These acids have many chemical, physical 
and pharmacological properties in common. Chemically 
they are all phenolic acids with the hydroxyl group 
in the ortho position relative to the carboxyl group.
COOH
0 “
COOH
CM,
COO H 
OH
COOH
Salicylic o-Oresotinlo m-CroBotinlc p-Oresotinle 
Acid Acid Acid Acid
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The above acids are all volatile in steam, 
soluble In hot wa.ter, alcohol, ether and chlox’oform, 
(Lange, 1946) and all give a purple odour virith 
ferric chloride. May (1909) found that the cresotinic 
acids resembled salioylio aeid in their action as 
antifermentatives, as bactericides, as antipjretioe 
and as specifics in acute rheumatism.
The qualitative similarity of these 
active acids both chemically and pharmacologically 
led naturally to the question of relative potency.
3)oes the introduction of a methyl group into the 
benaene molecule alter the potency of salicylate as a 
metabolic stimulant? To answer this question the 
coBiparative assay of the three oresotlnates against 
salicylate was undertalten.
The creaotinates were found to be more 
powerful metabolic otiiiiulante than salicylate when 
a.dBiinistered in single doses intraperitoneally to rata; 
ortho-cresotinate was the most powerful with a potency 
ratio of 2*61, meta-cresotinate had a value of 1.78, 
and para-cresotinate had a value of 1.89. The fiducial 
limits of the ratios slOTreci that these differences
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in the potencies of the three creeotinates relative 
to salicylate were significant at the 95?^  level»
The preceding potency ratios were calculated on a 
molar basis. The v#%es would be numerically lower, 
but equally significant, computed as weight for weight, 
but this would take no account of the chemical 
equivalence of the drugs.
The introduction of the methyl group into 
the benzene ring therefore increased the potency 
of salicylate as a metabolic stimulant; the ortho 
position was the most effective. This raised the 
question, which will be fully investigated in due 
course, of the effect of other alkyl or aryl substituents 
in the ortho position. It is of interest to note, 
that preliminary observations with 3-pheny]. salicylate 
suggest that it is even more potent than ortho-- 
cresotinate. The mean d Op of six rats who received 
single 50 mgm. doses of 3-phenyl salicylate 
intraperitoneally was f 162.1 mis./hr. (Table X33YIII).
This is approximately equivalent to the effect 
produced by 95 mgxm* ortho-oresotlnate » Higher 
doses of 3-phenyl salicylate killed the animals in 
hyperventilation and convulsions the same toxic
effects as salicylate and the cresotinates.
There were two obvious explanations 
to account for the higher potency of the oresotinateso 
The first of these was that the drugs differed in their 
primary actions.
It could be argued that if the conditions 
for the comparative assay were met then the drugs 
probably had a similar action. It was desirable, 
however, to put this to an experimental test. A study 
of the separate and combined actions of the drugs 
failed to establish a difference; administration of 
a mixture of salicylate and ortho™oresotinate gave 
a response indistinguishable from an additive effect. 
Thus, in the intact rat there was, potency excepted, 
pharmacologioally no appreciable or significant 
distinctionloetween the tv^ o acids.
The other main possibility was that the 
greater potency of the oresotinates was due to higher 
drug concentrations in the blood, which might easily 
occur as a .result of different rates of degradation 
and excretion. The analysis of covariance of the 
regressions failed to shov/ any difference in the rate
of degradation or exoretion.
This inference is, in itself of some 
interest, since it would have been reasonable to 
suppose that the incorporation of a methyl group 
into the benzene ring of salicylate would have at 
least altered the pz'oportions of the various detoxication 
products, end hence the overall rate of degradation 
and excretion.
It is concluded that the tissues themselves 
mustp therefore, be more sensitive to the cresotinates, 
and that-there must be true potency differences at the 
tissue level among the four acids® The explanation 
of this awaits further investigation®
Minor changes in the bensens molecule 
obviously alter the pharmacological activity® Points 
of interest which arose from this investigation were 
(i) for metabolic stimulant action, the carboxyl 
group must be free or at least not conjugated with 
glycine as in salicyluric acid nor with ammonia as in 
salicylamide, (11) the ortho-hydroxyl group cannot 
be replaced by an amino or carboxyl group without 
destroying the metabolic stimulating property, and
(ill) the presence In the ring of a. methyl group only 
destroyed the activity of salicylic acid when it 
occupied the 6-poBitioa i.e. the position ortho to 
the carboxyl group. It may be that the presence of 
the metliyl group in the 6-position is introducing 
some important steric effects. In the present series, 
a necessary condition for stimulant action was, 
therefore, the presence of a hydroxyl group in the 
ortho position only, relative to the carboxyl gz'oup; 
the addition of a second hydroxyl group to any other 
position in the benzene ring eliminated this action®
It is interesting to note that several of 
the above compounds have been used or tried 
therapeutically in the treatment of rheuma.tic fever.
In 1875, Buss announced his diacovexy of the therapeutic 
value of salicylic acid in acute rheumatic fever, 
and in the following year Buss (1876) published a 
further paper on the action of the closely related 
cresotinic acids showing that they exercised similar 
curative effects in this disease. Koranyi (1877) and 
Gatte (1879) (quoted by Demme, 1890) confirmed the
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antipyretie properties of the cresotinic acids and 
suggested their use in medical practice for feverish 
conditions® In 1890, Demme prepared pure samples of 
ortho-, me ta and para*-«cresotinic acids for 
physiological and therapeutic use and found sodium 
para-cresotinate to he harmless hut therapeutically 
effective in the treatment of febrile diseases® He 
stated that meta-cresotinate was less effective, and 
ortho-creBotinate, although acting quicker in smaller 
doses, was unsuitable because it caused paralysis 
of the heart muscles"^
May (1909) ha.s shown that the toxic effects 
of salicylate and the three cresotinates are similar® 
Comparable doses of the four drugs px’oduced dsath 
due to convulsions and hyperventilation, Stoelnaan (1912) 
using the sodium salts of the three cresotinic acids 
in the treatment of rheumatic feve%" concluded that5 
for practical purposes, they were inferior to sodium 
salicylate. He felt that, therapeutically sodium 
meta^-oresotinate had the same action and much the 
same value as sodium salicylate, the para- compound 
was distinctly less active and the ortho-compoimdp 
although very active, had an undesirable "slowing
and depressing influence" on the heart®
The work of Stockman and others has not been 
followed up, and apart from the introduction (Dobner, 
1930 and Eeischel, 1930) of Amatin, i.e. acetyl 
meta-eresotinic aeid, as a new oritipyretio aaid anti- 
meuralgesic, alleged to cause "no irritation of the 
stomach and no marked perspiration" the cresotinic 
acids have remained almost unknown as therapeutic 
agents «
The isomers of salicylic acid - meta- and 
para-hydroxybenzoic acid are ineffective in the 
treatment of rheumatic fever (Stockman 1920), 
and although selioylamide (Li^er, Moreno and Donin, 1951 
sodium gentisate, (Meyer and Hagan, 1946), sodium 
Y -resoroylate (Reid, Watson, Cochran and Sproull,
1951) and 2g3-dihydroxybenzole aeid (Miehotte and 
Banaux, 1952) have all been reported as effective 
in the treatment of acute rheumatism, none has yet 
replaced the old established drugs - aspirin and 
sodium salicylate. The present results sho%f that 
many of these antirheumatic drugs fail to increase 
the metabolic rate of rats. of them are, in
fact, depressants* In the past, several v/orkers 
(Cochran, 1952, Hall, Tomich and Woollett, 1954, Held,
1957, Adams and Oobb, 1958) have dlBOUssed the 
possible mode of action of salicylate in rheumatio 
fever and related it to its metabolic stimulating 
property without producing any cono3.uBiYe evidence.
It is clear, however, from the present results, that 
ability to increase metabolic rate is not essentiel-, 
although, within this series, it may be sufficient 
for antirheumatic activity®
Salicylic aeid and 2:4-dinitrophenol are 
well known metabolic stimu3-ants; slight changes in the 
salicylate molecule can eliminate this effect* 
Similarly, Cameron (1958), in her study of the 
nitrophenols3 found that 2i4™dinitrophenol and its 
methyl derivative, dinitro-ortho-creaol, were the 
only compounds which increased the oxygen consumption 
of rats.
lo no rail sat ions have yet been made for 
the phenolic acids but it appears that they are as 
specific as the nitrophenols, since only ortho- 
hydroxybenzoic acid and the 3? 4? and 5 methyl 
substituted derivatives had metabolic stimulating 
properties*
The immediate importance of the present 
investigation is that it forms a foundation for further
studlee by physical chemists and pha^rmaeologietSo 
What physical properties of salicylate and the 
cresotinates account for the present potency ratios 
of these drugs as metabolic stimulants in the intact 
rat? This fundamental question is posed rather than 
answered by the present results.
*■84*
ÂBpeMix.
■85-
Btatietical Methods.
— <y. "Mf'i 4 a * i>^ ‘ffft-„T aw .i^ '*i, i ig te 3 « e g r .!.,iw n rw i:«n p f lga j B j n 'A»
Comparative dilution assay of foux" metabolic stimulants*
(Silvey, 1958).
(1)9 Analysis of variance0
Soux^ ce of variation Sum of squares d.f.
2Between intercepts np Sv  ^ m-1- ■ ■ X
Deviation of mean ■ m
response from linear n By, m(p-2
regression
Residual 8^  mp(n-l)
Til » Number of drugs,
p - lumber of doses for each drug.
n - lumber of individuals receiving dose % y of drug I 0
^  - is bhG mean response bo close oCy of ârug t.
—86—
, 2 „ „ 2 ^ ^ 2  2
*33 “   •'DeiX 2
b.
Z 4  -V
j
21 - mean dose of drug i •
“ overall mean reeponse to drug i «
^ f) T ?
A Gomparisoii of n S-A with 8 byli mpvn—X/
means of an Retest decides whether the regressions
of response on dose are linear.
c  ^  ^ a *5 „■?
- u/, a, 4-  - Wo.
*^* «3
Oj is a weighted sum of squares for the a ^ *s®
Z - v
j
(a/“ ” CJI +     ^  ^
a. —
1 2  1 2A comparison of npB^ with decidoj
whether the intercex)ts are all the same •
—B7—
(2) Eatimatlom of potency ratio.
The regression of drug c Is of the form j - aC 
where cL does not depend on c . Using this fact we 
obtain an estimate of pi better than
t;.
Ow
r
S.
DC
V
Estimate of the variance of is
/^ LL + ±
Ù w Z: V
aiia the covariance of. aacî bj^
n n
ac ; ur
^ is the residual mean square in the analysis 
of variance above®
Potency ratio P h'
kcrcnrrsaiTC?--£-
(3) 95# confidence limits ( ®g)
G I miâ B p a re  th e  s m a lle r  end la r g e r  ro o ts  o f  th is
V
e q u a tio n  e t  ie  th e  5# value of a t-*ci is  t r ib u t  io n
w ith  m p(m -l) degrees o f freedom *
to Tables,
Tables - 300CIII give the results of the experiments 
to determine 'the effect of eighteen substituted 
benzoates on the rate of oxygen oonsumption of Wietar 
albino rats*
Tables XXXIY - ZXXYII give the results of the dose- 
response experiments for salloylio acid, ortho-, meta- 
and para-GX'esotinio acid®
Tables XIXYXII XLIII give the results of the combined 
action experiments of salicylic acid and ortho-cresotinlc 
acid.
Tables XLI¥ « XLYII give the results of the time 
concentration experimente for salicylic acid, ortho-, 
meta- and para-cresotinic aeid.
The effect of 120 mgms® salicylio acid on
of Wietar 8.1bino rate.
Mo* Bate Sex
Weight 
gms •
2
mls./hr. 
Control ®ï?eated 
(2) (1)
Biff, AOg
ml s./hr. 
(1)—(2)
1 29.11*56. I? 242 537.0 614.8 +77.8
2 30.11*56* m 290 420.4 454.4 +34.0
3 3*12.56. I 256 357.2 386.4 +29.2
4 3*12.56. M 284 332.9 498.2 +165.3
5 4.12.56* M 269 354.8 420.4 +65.6
6 4*12.56* p 240 461.7 444.7 -17.0
7 5.12.56. M 290 393.7 471.4 +77.7
8 6.12.56. M 268 430.1 456.8 +26.7
9 7*12.56. F 250 435.0 493.3 +58.3
10 7*12.56. I 265 466.6 483.6 +17.0
Average 418.9 472.4 +53.5+34.6
accepted (Z = 5.61)
Table X¥ÎI*
effect of 500 m. hyclroxybenzolo acid on
the oxygen consumption of Wlstar albino rats.
mo. Date Sex
Weight
gmo.
mis./hr. Dtlfï.AOg
Control tPreated mis ./hr. 
(2) (1) (l)-(2)
1 11.12*56* m 270 418.0 308.6 —109.4
2 12*12*56* 1 256 425.3 252.7 -172.6
3 13*12.56. M 255 420.4 308.6 -111.8
4 14.12.56* 1 275 418.0 260.0 -150.0
5 14.12.56. 3? 256 617*2 284.3 -332.9
6 17*12.56. f 270 447.1 294.0 -153.1
Average 457.7 284,7 •-173.0+103.
aoGGpted (Z - 5.05)
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I’ahle XVIII.
The Effect of 500 mmis. w. hydro %.yh en go 1 c acid oa
the oxygen ooneuraption of Wistar albino rats#
Oo oonsvMption
n-s ‘p-p l\
lo. Date Se3s
Weight
gms.
Control Treated mis,/hr* 
(2) (1) (l)-{2)
1 2.2.57. M 238 342.6 323.2 -19.4
2 3,2.57. M 260 478.7 364.5 -114.2
3 3.2,57. M 264 410.7 315.9 —94.8
4 6.2.57, M 258 405.8 330,5 -75.3
5 7.2.57, 3? 230 296.5 255.2 -41,3
6 7.2.57. P 233 442.3 279.5 -162.8
7 8.2.57. 1 262 342.6 325,6 -17.0
8 8.2.57. E 260 558.9 459.3 -99.6
Average 409*8 331#7 -78.1^42.1
!L aooeptecl (Z - 5*86)*
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Table XIX.
The effect of 100 rams. 2^g-Alhydrozybeziaolo ae:
on the QJiyRmi consumption of Wlatar albino rate
Og eonaumptlon
lo. Date Bmi
Weight
gme.
mlB./hr.
Oontrol ï^ reateâ mis./hr. 
(2) (1) (l)-(2)
1 10.9.57* W 255 498.2 495.7 ”•2.5
2 10.9.57* w 246 431.0 612.0 +181.0
3 10.9*57* p 245 330.5 267.3 -63.2
4 10.9.57* p 255 479.4 288.2 -191.2
5 11.9*57. m 242 420.4 371.8 -40.5
6 11.9.57* m 260 448.8 385.1 -63.7
7 11.9.57* ■ M 240 471.8 397.8 -74.0
a 11.9.57* m 232 376.7 430.1 +53.4
9 12.9*57. p 232 392.7 336.6 -56.1
10 12.9.57. M 230 381.5 376.7 —4.8
11 12.9.57* M 248 447.1 405.8 -41.3
12 12.9.57. M 260 482.0 487.1 +5.1
Average 430.0 404.5 -25.5+55
accepteâ - 1.01)
*="94—
fable I X .
B effect of 500 mgms* 2ii4-ciiIijdroxTben5îoio acid
on the o%Ymn eonsimption of Wietar albino rate#
Or) oonamiwtlon 
‘ mla./k...
»
Mo. Date Ses gms. (2) (1) (l)-(2)
1 24.12.55. P 260 471.4 354.8 -116,6
2 24.12.56. P 258 413.1 320.8 -92.3
3 27.12.56. P 267 459.3 437.4 -21,9
4 27.12.56. M 264 493.3 388,8 -104,5
5 20.12.56. P 241 464.2 301.3 ""152 « S
6 28,12.56. M 252 478.7 432.5 •*4'^ * 2
7 4.1.57. 1 242 415.5 369.4 —46 #1
Average 456,6 372.2 "“04 « 4^44 •
11^ aeoepted (Z = 5*4^)*
«v95—
Table M I.
I "Il \wmrn tm ■ ’ w w w " T  n r t  : »
fhe effect of 500 mgma * 2 sânoscyben^olc aoid 
on the oxygen oonsumption of Wietar albino rats.
r ^ i « w u « J jn u - iw— ■wwteiew ii'iBÆ-UlJfc.,. I ■<»r ■ «— WRig— wij!a*t-'g
Mo 9 Date Be%
Weight
gmOf
ml B./Sir. 
Coîitz’ol Treated 
(2) (1)
Biff.A 0
mis./hr. 
<l)-<2)
1 9.1.57. m 265 471.4 102,1 -369.3
2 10.1.57. M 280 539.5 114.2 -425.3
3 14.1.57. 3? 265 476.3 150.7 -325.6
4 15.1.57. M 262 507.9 160.4 “347.5
5 16.1.57. P 255 398.5 150.7 -247.8
6 16.1.57* D 260 452.0 170.1 -281.9
Average 474.3 141.4 -332.9+71.6
aceeptod (2 = 5.83).
XKll.
fte effect of 200 mgme. 2î6-âihydroxybensoic aold
oa the oxygien Gonaiiiaption of Wlatar albino rats.
So. Date Bbx
&
mis./hr. 
Weight Control Treated 
gms, (2) (1)
M f f . A 0„d.
mis */hr, 
(IMS)
1 12.3.57. m 261 495.7 345,1 «150*6
2 13.3.57. M 243 364.5 340.2 «24.5
3 13.3.57. M 260 517.6 257,6 -260*0
4 14.3.57. 1 232 425.3 376.7 «43 # 6
5 14.3.57. 3? 234 442.3 332.9 ■**109 *4
6 15.3.57, P 234 371.8 255.2 «116*6
7 15,3.57. P 240 452.0 311.0 ■=141.0
Average 438.4 316.9 -121,5+71.0
H. accepted (Z = 5.22) #
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TahlB XIIII*
The effect of 500 mgme* 3 g 4«dlhydroxybengoio acid 
on the oxygen ooneumption of Wietar albino rats*
.-TK" K'Tirv - * - V — ' "(V," , ' —' «L'l 1.^  ««i '!■ M n  1- liT.* >■" j f *n m -wm. w  "w «T-m-j j * —TL"r w i ' i . ,'L#";r. i t 'T L ' ■■■■>■ •• ' .«r j f  j*q
Mo. Date Bex
Weight
gtUB •
p>- vIL w%l
mla./hr. 
Control Treated 
(2) (1)
Mff. AO
mis./hr. 
(l)-(2)
3. 18.1.57* P 263 522.5 320.8 -191.7
2 21.1.57. P 247 398.5 522.5 +124.0
3 22.1.57. M 253 449.6 308.6 —141.0
4 23.1.57. f 240 451.4 369.8 —81.6
5 23.1.57. M 243 430.1 342.6 -87.5
6 24.1^57. P 236 410.7 291.6 —119.1
7 24^1,57. M 268 469.2 451.4 -17.8
8 25.1.57. If 248 545.7 369.8 -175.9
9 25.1.57. m 236 396.1 238.1 -158.0
10 2.2.57. M 260 473.9 303.8 -170.1
Average 454.8 351.9 --102.9+67
aeoepted (Z = 5*TO)
9 8 .
Table XXS¥.
She effeot of 500 gfcms, SsS-clihydrosr.y'benaoie acid
on the oxygen consumption of Wistar albino rats*
So, Date
1
Bex
9^ eight 
gî’ae*
Lf VlAa LiHi^ U.A.UZA
mlB./hx', 
Control Treated
(2) Id
Biffa A ri
mils a/hr*
(1)»C2)
1 18.2.57. 1 244 546,8 340,2 -206,6
a 18.2,57. M 263 483.6 413,1 -70.5
3 19.2,57. P 270 447,1 349,9 -97,2
4 21,2,57. P 248 401,0 342,6 «58 « 4
5 21,2.57. M 243 493,5. 340,2 «153*1
6 22.2,57. P 278 418.0 401,0 -17*0
7 22,2.57. 1’ 255 475.5 347.5 «128,8
Arerage 4.66,6 352.1 .-104*5^69.9
% accepted {Z 0
.90
T a b lo IX?.
The effect of 100 mgms. 5-aminosal 1 ey 11 o aoici on the
oxygen oQBsumi>tion of Wlstar albino rats.
Og consumption 
als A O
lo. Date Sex gms. (2) (1) (l)-(2)
1 3.4.57. M 254 422.0 401,0 -21.8
2 3.4.57. P 230 366.9 298.9 -58.0
3 3.4.57. M 270 4-20*4 267.7 —150.7
4 3,4.57. F 235 369.8 280,5 -89.3
5 1,5.57. M 232 461.7 352.4 -109.3
6 1.5.57. F 230 321.3 285.6 -35.7
7 2,5.57. M 255 425.9 244. S -181.1
Average 399.5 304.4 -95.1+55.
% accepted (Z = 5.22).
fable XXVI.
The effect of 100 mgniB. aalAoyluric acid on the
Gomsmmtlon of Wiatar albino rats.
M BS.'SB Î'Æ KW .'
lo. Date Sex
Weight 
gms.
 ^ il JL
mis./hr. 
Control Treated 
(2) (1)
M f f . AO,
tals./hr.
(l)-(2)
1 4.4.57. M 254 427.7 432.5 +4*Q
2 4.4.57. 1? 272 418.0 352.4 «6§*6
3 5.4.57. M 232 357.0 321.3 «35*7
4 5.4.57, I 231 544.3 275.4 «68.9
5 .30.4.57. m 240 306.4 357.2 «29.2
6 1.5.57. if 253 374.2 325.6 «48 « 6
7 1.5.57. M 260 479.4 367.2 «112.2
8 1.5.57. P 240 321.3 300.9 «20.4
Average 308.6 341.7 --46.9±29.^
Si aooepted (Z = 5.32) #
10]..
fable XXVII.
The effect of 50 mgrne* aalloylamlde on the oxygen
oonBtïia'Dtlon of Wistar albino rats.
Or) eonsumption
mis. Air * ^
' lo. Bate Bex
Weight 
gms.
Control
(2)
Treated
(1)
mis./hr.
( 1 M 2 )
1 1*6^57. M 242 335.3 296.5 -38,8
2 1.6.57* 1 260 354.5 196,4 -158,1
3 17.7.57, W 244 449 .6 308.6 -141.0
4 17.7.57* M 282 494.7 372.4 -122.4
5 18.7.57. 3? 245 388.8 240.6 —148 *2
6 18.7.57. M 285 433,5 270.3 -163.2
Average 409.4 280.8 -128,6+46.8
IL aoaepted (Z » 5*43).
.102.
fable XX.?!!!.
The effect of 100 mgms .io acid on
the oxygen consumption of Wlstar albino rats
fTrCiTA b r -wJ^ z.z5TTlK_A5l^Lwtfi^CZ%AT,._r.JlSMkni r yA.l fd.lL, J—Itv-LLiUV i " '  II' 'I’. i '- . j . i—!l I-'. +-!'■-wi' LT%# " i|T"T ^T r# f
lo. Date Ses
Weight
gms.
V/ g  tÆiii y  VA, UA A
ml8./hr. 
Control Treated 
(2) (1)
Diff. A O
mis./hr. 
(1)~(2)
1 21.3.57. V 246 390.2 487.1 +96.9
2 21.3.57. P 236 403.4 565.0 +161»6
3 21.3.57. M 245 257.6 558.5 +300.9
4 22.3.57. f 236 418.2 520,2 +102.0
5 22.3.57. M 250 405.3 661.0 +255.2
6 22.3.57. M 278 497.3 599.3 +102.0
7 22.3.57. P 238 398.5 612.4 +213.9
Average 395.9 572.0 +176.1+76
ÎL accepted (Z = 5.89).
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Table IXIX.
The effect of lOOmgms. 4-methyl sallcylio aeld on
.fffiTW  I.im  I.ir I "a
the oxygen cOBsmnption of Wiatiar albino rats.
Ho Data
Weight 
, Bex gms.
0^ oonQiuïiptlon
Control Treated 
<2) (1)
Dlff.6 0^
mis*/hr. 
(1)«(2)
1 18.7.57. M 268 356.9 488.3 4-121.4
2 18.7.57. M 285 529.0 456.5 +127.5
5 19.7.57. F 240 415.1 532.2 +119.1
4 19.7.57. * M 232 380.0 515*1 +135.1
5 29.7.57. F 232 403.4 439.8 +36*4
6 29.7.57. P 236 418,2 538.1 +119.9
Average 385.1 495.0 +109*9+33.
% acoepteci {Z - 5.49) * ‘
"X04«
The effect of 105
« K K T 3 « a iê e » ia c .'jf :
the
Table XXX.
n of Wistar albino rats*
: jLC;%rTYTa3.^UJ2?r j. : . i# ^ c w J K Z : '= i: 'u % ic K ,^ u ja :v n M ,' . i y ’ a g g t i o o w »
Mo. Bate Sex
Weight 
gms *
0^ aonsumpt2.cn
mis./hr* 
Control Treated 
(2) (1)
Mff. A0„ 
mis./hr.
(l)-(2)
1 6*5*57. m 250 369.4 583.2 +213.8
2 23*5*5?. p 238 315.5 459.3 +145.8
3^ '6.5*57* M 246 318.8 632.4 +313.6
4 23.5*57. P 230 441.2 589.1 +147.9
5 6*5*57* M 230 447.1 524.9 +77. S
6 24*5.57*. f 230 318.3 532.2 +213.9
T 24*5*57* M 285 545.7 678.3 +132.6
8 24*5*57* W 238 311.1 558.5 +247.4
Average 383.2 569.8 +186.6+62.9
accepted (z = 5*25)*
«10 5«
Table XXXI.
The effect of 24 mgms. 6«aiethjl saliGjlic acid on
^ SXÎ =Ct U:r .^  i S = S t K T C x r i à « r i'S.'msrzX T '■*-.- i r -m iggsa r f  Jr?■lsVW=iC^3aîiU:j1^6w=;:fA’Siî3F3S?<i^^ K C = ti
the oxygen consumption of Wistar albino rats.
Of) consumption
lo. Date Ses
Weight
gms.
6:
mis
Control
(2)
./hr.
Treated
(1)
Diff. AOg
mis./hr, 
(1)“(2)
1 30.7.57. F 232 377.4 364.7 -12.7
2 30.7.57. W 250 444.7 376.7 —68.0
3 9.9.57. F 275 461.6 405.5 -56.1
4 . 9.9.57. F 250 393.7 609.9 +216.2
5 13.9.57. M 230 359.6 390.2 +30.6
6 13.9.57. M 255 393.7 481.1 . +87.4
? 16.9.57. M 268 486.0 544.3 +58.3
8 16.9.57. M 235 494.7 510.0 +15.3
9 18.9.57. P 846 397.8 410.6 +12.8
10 18.9.57. F 256 617,2 549.2 -68.0
Average 442.6 464,2 +21.6+61.7
accepted (Z = 0.65)*
"106'
Table mil.
The effeot of 100 mgras. O'-amiaobenaoio a old oa the
>f Wistar albino ra,ts*
Mo. Date S ex
Weight
gms.
' «la.Ar.
Ooatrol Treated mie./hr,
(2) (1) (1)—(2)
1 28.5.57. m 263 545.1 232.7 —92.4
2 28.5.57. F 232 566,9 332.9 -34.0
3 31.5.57. M 283 359.6 295.0 -63.8
4 31.5.57. M 286 580.0 334.1 -45.9
5 31.5.57. P 230 379.1 323.2 -55.9
6 31.5.57. 1 265 437.4 281.9 -155.5
7 1.6.57. H 247 385.1 351.9 -33.2
Average 379.0 310.3 •-68.7+40.7
acecpted (Z - 5.12)
.107,
Table XXX.IIÎ.
The effect 0f 100 Bigais « Dhthalic Acid on the oxyge:
oonsumptloa of Wlstar albiao ra’
lo. Date ' Ses
Op ooîisumptiOH
aie./hr. 
Weight Control Treated 
gms. (2) (1)
Diff. AO-
mis./hr. 
(l)-(2)
1 13.9.57. W 255 517.7 408.0 -109.7
2 13.9.57. F 232 461.7 469.0 +8.3
3 19.9.57. M 240 476.3 435.0 -41.3
4 19.9.57. M 232 357.0 374.9 +17.9
5 20.9.57. F 250 473.9 435.0 -38.9
6 20.9.57. F 245 428.4 382,5 -45.9
7 25.9,57. M 240 469.2 436.1 -33.1
8 25.9.57, M 270 487.0 609.9 +122.9
9 26.9.57. W 232 405.4 402.9 -2.5
Average 452.9 439.3 •”13.6+48.9
L accepted (z = 0.44).
Table IXXI?.
Oxygen oonBumptloa of rats after injection of
aalioyllc acM.
Mo. Date
Dose
rngms.
wt.
gms. Bex
Op ooneiimptioB
mlBa/te.
0 out rol Tre at e à 
<2) (1)
MffwûOg
mis./hr. 
(1)“(2)
1 1.10*57* 30 225 .? 428.4 451.4 +23.0
2 15.10.57, 30 210 m 444.7 388.8 -55.9
• 3 18.10.57* 30 p 372,3 395.3 +23.0
4 5.11o57. 30 210 p 284.3 403.4 -119.1
5 7.11*57. 30 210 m 362.1 367.2 +5.1
6 12.12.57. 30 207 p 422.8 398.5 -24.3
7 , 13.12:57. 30 210 m 402.9 397.8 -5,1
8 18.12.57. 30 203 M 408.2 301.3 -106.9
1 '20.12.57* 60 202 p 590.2 321.3 -58.9
2 9.1.5a. 50 220 M 418.0 345.1 -72.9
3 13.1.58c 60 212 I 436.1 385.1 -51.0
4 16.1.56, 60 232 M 415.5 369.4 —46.1
5 20.1.58. 60 202 m 364.7 385.1 +20.4
6 21.1.58. 60 225 p 408.2 408.2 0
7 22.1.58. 60 200 M 334.1 321.3 -12.0
8 13.2.58. 60 175 P 359.6 306.4 +26.8
1 2.10.57# 90 238 M 427.9 418,0 -9.9
2 7.10.57# 90 229 M 413.1 433.5 +20.4
3 10.10.57. 90 208 P 340,2 454.4 +114.2
4 14.10.570 90 205 P 323.9 374.9 +51.0
5 8.11.57. 90 205 J? 452.0 454.1 +2.1
6 27.11.57. 90 205 m 352.4 403.4 +51.0
7 28.11.57. 90 244 p 346.8 446.3 +99.5
a 2.12.57# 90 203 M 364.7 433.5 +68.8
9 17.2.58. 90 180 }? 374.9 482.0 +107.1
10 28.2.58c 90 230 M 383.9 403.4 +19,5
11 4.3.58. 90 240 M 441.2 431.0 -10.2
12 7.3.58. 90 230 P 447.1 349.9 -97.2
eontd#
.109'
Table XXXIV. (conta.)
Baliùyllo Aciâ.
Mo, M t e
Dose
•fflgîïlS .
Wt.
gms. Sex
mls./iir. 
Control Trea'bed 
(2) (1)
Mff.AO,
(l)-(2)
1 30.9.57. 120 238 ffl 454.4 478.7 +24.3
2 8.10.57» 120 235 1 374.2 388.8 +14.6
3 9.10.57. 120 205 F 402,9 428.4 +25,5
4 17.10.57. 120 223 F 382.5 448.8 +66,3
5 6.11.57. 120 210 F 422.8 396.1 -26.7
6 14.11.57.- 120 208 M 308.6 500.6 +192.0
7 26.11.57. 120 215 H 329.0 415.7 +86,7
8 11.12.57. 120 210 M 349.4 357,0 +7.6
9 19.2.58. 120 205 F 349.4 385.1 +35.7
10 26.2.58. 120 230 M 437.4 486.0 +48.6
11 5.3.58. 120 190 F 328.1 485.0 +157.9
12 6.3.58. 120 175 M 362.1 482.0 +119.9
1 19.12.57. 135 224 f 342.6 503.0 +160.4
2 10.1.58. 135 215 M 392.7 487.1 +84.4
3 14.1.58. 135 244 M 420.4 476.3 +55.9
4 15.1.58. 135 204 M 357.0 502.4 +145.4
5 17.1.58. 135 203 M 430.1 486.0 +55.9
6 10.2.58, 135 204 F 339.2 499.8 +160.6
7 11.2.58, 135 200 F 357.2 522.5 +165.3
8 12,2.58, 135 195 F 354.5 364.7 +10.2
9 18,2.58. 135 235 M 391.2 413.1 +21.9
10 20.2.58. 135 200 M 336.6 346.8 +1Ô.2
11 25.2.58. 135 230 F 386.4 444.7 +58.3
12 27,2.58. 135 205 F 321.3 502.4 +181.1
1 4.10.57. 150 225 F 369.8 436.1 +66.3
2 11.10.57. 150 220 F 364.5 556.5 +192.0
3 21.10.57. 150 230 F 408,2 432.5 +24.3
4 4.11.57. 150 205 m 323.9 471.8 +147.9
5 11.11.57. 150 205 M 339.2 494.7 +155.5
6 • 29.11.57. 150 203 M 323.2 473.9 +150.7
7 16,12.57. 150 220 M 401.0 469.0 +68.0
8 17,12.57, 150 240 F 433.5 418.2 “15.3
9 14.2.58. 150 225 M 381.5 583.2 +201.7
10 21.2.58. 150 205 F 349.9 478.7 +128,8
11 24.2,58. 150 215 M 387.6 517.7 +130.1
12 3.3,50. 150 210 F 420.8 431.0 +10.2
2
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of Table XXXI?,
mgme,
Efeaa A 0 
ml8./hr.2
60
135
150
^.5
- 25.6 
+34. T 
+62.7 
+92.5 
+105.2
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Table IlXf.
Oxygen eonsumptlon of rats after injeetion of ortho-
cresotlnio acldj.
Op Gom^umptloB
’■ mis./hr. Diff .40,
lo* Date
Dose 
Higias.
Wt.
gms. Bex
Control
(2)
Treated
(1)
1 4.10.57. 25 243 P 323.2 320.8 —2.4
2 11»10.57. 25 210 P 405; 5 402; 9 —2 *6
3 21,10.57. 25 215 P 397.8 415; 7 +17.9
4 4.11.57. 25 215 M 413.1 349.9 -63.2
;. 11,11.57. 25 204 M 323;2 466.6 +143.4
s 29,11,57, 25 215 M 400.4 400.4 0
t 16,12,57, 25 238 M 456.5 397.8 -58.7
8 17,12,67. 25 218 I 452.0 390.5 -53.5
1 1,10.57. 50 24Ü ' P 473.9 449.6 -24.3
2 15.10.57. 50 205 1 428.4 448.8 +20.4
3 18.10.57. 50 230 P 418.0 425.3 +7.3
4 5.11; 57'. 50 P 438.6 ' 415.7 -22.9
5 7.11.57; 50 201 1 405 ;8 422i8 +17.0
6 12;12.57. 50 230 F 405.5 346.8 -58.7
7 13.12;57. 50 205 M 403.4 471.4 +68*0
• 8 18.12.57. 50 215 m 436.1 459.0 +22.9
1 19.12,57. 62.5 240 p 479.4 484.5 +5.1
2 10,1.58. 62.5 232 M 374.2 403.4 +29.2
3 14.1.58. 62.5 230 M 382.5 441.2 +58.7
4 15.1.58. 62.5 204 M 381.5 486.0 +104.5
5
6
17.1.58. 62.5 203 M 385.1 408.0 +22.9
10.2.58. 62.5 200 P 383.9 435.0 +51.1
7 11.2.58. 62.5 200 F 331.5 469.2 +137.7
8 12.2.58. 62.5 190 I 337.8 388.8 +51.0
9 19.2.58. 62.5 245 P 320.8 473.9 +153.1
10 26.2.58. 62,5 225 M 318,8 474.3 +155.5
11 5.3.58. 62.5 185 P 341.7 420.8 +79.1
12 6.3.58, 62.5 195 M 301.3 439.8 +136.5
c ontd. 
«XX 2«
liable (cantâ.)
o«QrG.30tinic Acid*
côïî.Bim?)tiOB
»l=./to. M f f  J O 2
Bose Wt,
+94.3
+198.9 
+211.4 
+102.0 
+43.3 
+104.6 
+199.3 
+36.8 
+63.2 
+170.9
+138.5
+165.8
+157.9 
+89.3 
+80.1 
+140.2 
+247.9
+140.2
+92.3
+183.6
+174.0
+23.0
+155.5
+131.3
lo. Bate mgras. gras. Sex (2) (1)
1 30.9.57. 75 220 m 476.9 571.2
2 8.10.57. 75 220 F 359.6 558.5
3 9.10.57. 75 215 I* 318.3 529.7
4 17.10.57. 75 230 3? 376.7 478.7
5 6.11.57. 75 235 F 436.1 479.4
6 14.11.57. 75 225 M 316.2 420.8
7 26.11.57* 75 201 M 422.8 622.1
8 11.12.57. 75 205 K 454.1 490.9
9 17.2.58. 75 175 1? 359.6 422.8
10 28.2.58. 75 220 M 377.4 548.3
11 4.3.58. 75 250 M 381.5 520.0
12 7.3.58. 75 205 F 392.7 558.5
3 20.12.57. 87.5 203 J? 352.4 510.3
2 9.1.58." 87.5 203 m 346.8 436.1
3 13.1.58. 87.5 215 1? 376.7 456.8
4 16.1.58. 87.5 200 M 400.4 540.6
5 20.1.58. 87.5 202 M 315.9 563.8
6 21.1.58. 87.5 222 F 374.9 515.1
7 22.1.58. 87.5 215 M 413.1 505.4
8 13.2.58. 87.5 195 f 367.2 550.8
9 14.2.58, 87.5 220 M 372.3 546.3
10 21.2,58, 87.5 180 I? 397.8 420.8
11 24.2.58. 87.5 240 M 376.7 532.2
12 3.3.58. 87.5 215 J? 439.8 571.1
1 2.10.57. 100 210 1 420.8 734.4
2 7.10.57. 100 248 M 495.7 731.4
3 10.10.57. 100 230 f 385.1 721.7
4 14.10.57. 100 220 F 379.1 590.9
5 8;11.57. 100 210 F 415.7 507.5
6 27.11.57. 100 215 M 392.7 624.8
7 28.11.57. 100 244 F 425.3 529.7
8 2.12.57. 100 200 M 461.7 546.8
9 18.2.53. 100 220 M 410.6 487.1
10 20.2.58. 100 235 M 420.4 624.5
11 25.2.58. 100 200 F 385.1 561.0
12 27.2.58. 100 215 F 422 480.4
-113-
+313.6
+235.7
+336.6
+211.8
+91.8
+232.1
*ii04.4 
+85.1 
+76.5 
+204.1
+175.9
+65.6
Q«OreBQtlniQ Aolcl*
Bôse
O’mpi
A O  
nûLs./ïîr 2
25
75
87.5
—2. 4
+3.7
+82 . 2 
+127.4 
+134.7 
+177.8
gjable XXl¥Io
’gen consmipMonofrate after injection of me ta-
OTeeotinic acid,
Og conBumptlon
Dose Wt.
•Ho. Date ragas. gms. Sex (2) (1) (l)-(2)
1 2.10.57. 25 240 M 439.8 403.4 —36.4
2 7.10.57. 25 238 M 464;! 441.2 -22.9
3 10.10.57. 25 246 3? 415.5 422.8 +7.3
4 14.10.57. 25 210 F 438.6 367.2 —71.4
S 8.11.57. 25 213 F 425.3 386,4 -38.9
6 27.11.57, 25 203 M 328.1 357.2 +29.1
7 28.11.57, 25 233 F 377.4 339.2 -38,2
8 2.12.57. 25 203 M 459.0 369.8 -89.2
1 4.10.57. 50 215 F 362.1 339.2 -22.9
2 8.10.57. 50 248 F 388.8 374.2 —14 .6
3 9.10.57. 50 205 F 349.4 326.4 -23.0
4 17.10.57. 50 220 F 397.8 308.6 -89.2
5 11.11.57. 50 210 M 390.2 385.1 -5.1
6 14.11.57. 50 203 M 388.8 391.2 +2.4
7 26.11.57. 50 216 1. 346.8 400.4 +53.6
8 11.12.57. 50 210 H 293.3 349.4 +56.1
1 20.12.57, 62.5 202 .? 385.1 433.5 +48.4
2 9.1*58. 62.5 232 M 347.5 418.0 +70.5
3 13.1.58, 62.5 202 F 545.7 482.0 -63.7
4 17.1.58, 62.5 202 M 349.9 357.2 +7.3
5 20.1.58, 62.5 1 397.8 433.5 +35.7
6 ■21.1.58, 62.5 202 F 376.7 430.1 +53.4
7 22.1.58, 62.5 225 M 448.8 451.4 +2.6
8 13,2.58, 62.5 175 F 364.5 391.2 +26.7
9 18,2.50, 62.5 245 M 403.4 454.1 +50.7
10 20.2.58. 62.5 185 M 425.9 420.8 -5.1
11 25.2.58. 62.5 225 F 408.2 437.4 +29.2
12 27.2.58. 62.5 195 F 390.2 372.3 -17.9
contd *
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Table XXIVI, (contd.)
m«Oresotinie Acid.
Og eonsimiptlon
ml s */hr * Dxx ,L *û 0^ 
D o b q Wt* Control treated mis*/hr.
Mo, Bate mgms, gms. Sex (2) (1) (1)“(2)
1 1 ,1 0 ,5 7 * 75 210 $80.0 402,9 +22.9
2 1 5 ,1 0 ,5 7 , 75 208 1 4$2,0 512,7 +50.7
3 1 8 ,1 0 ,5 7 , 75 208 f $41,7 443,7 +102.0
4 5 ,1 1 .5 7 , 75 243 If 465.6 558.9 +92.3
5 7 .1 1 ,5 7 , 75 220 M 433,5 448.8 +15.3
6 1 2 ,1 2 .5 7 , 75 212 P 418.0 493.3 m , 3
7 13,12,57, 75 240 M 402,9 484.5 +81 .6
8 1 8 .1 2 ,5 7 . 75 205 M 388. S 437.4 +48.5
9 1 4 ,2 .5 8 , 75 190 M 376.7 522,5 +1.45.8
10 2 1 ,2 ,5 8 . 75 210 P 383.9 452.0 +68 .1
11 2 4 ,2 .5 8 , 75 200 M 372.3 466.7 +94.4
12 3 ;3 .5 B . 75 185 P 397.8 431.0 +33.2
1 1 9 ,1 2 ,5 7 , 8 7 .5 204 p 371.8 452.0 +80.2
2 1 0 .1 .5 8 . 87,5 202 M 341.7 372,3 +30.6
3 1 4 ,1 ,5 8 . 8 7 ,5 238 M 383.9 442 « 3 +58.4
4 1 5 ,1 .5 8 . 8 7 .5 204 M 380,0 474.2 +94.2
5 1 6 ,1 ,5 8 . 8 7 .5 202 M 388.8 469.0 +80.2
6 1 0 .2 .5 8 , 8 7 .5 215 P 377.4 476.9 +99.5
7 1 1 .2 ,5 8 . 87,5 200 f 374.2 507.9 +133.7
8 1 2 .2 .5 8 . 8 7 ,5 185 P 390.2 428,4 +38.2
9 17.2.58. 8 7 .5 185 f 357.2 405.5 +38.3
10 2 .3 ,5 8 . 8 7 ,5 225 M 315.9 495.7 +179.8
11 4,3,58. 8 7 ,5 225 M 308.6 512.6 +204.0
12 7 ,3 ,5 8 . 87,5 185 I? 337.8 401.0 +63.2
1 30.9.57, 100 220 M 456.8 471.4 +14.6
2 1 1 .1 0 ^ 5 7 , 100 220 P 418.0 503.0 +85.0
3 2 1 ,1 0 ,5 7 , 100 232 I 405.8 459.0 +63.2
4 4 .1 1 .5 7 , 100 228 M 492.2 553.4 +61.2
5 6 ,1 1 .5 7 . 100 212 P 437.4 449.6 +12.2
6 2 9 .1 1 .5 7 , 100 202 i: 386.4 495.7 +109.3
7 1 6 ,1 2 .5 7 . 100 203 M 422.8 561.3 +130.5
8 1 7 .1 2 .5 7 . 100 223 If 367.2 428.4 +61.2
9 1 9 .2 .5 8 . 100 180 1 318.8 466.7 +147.9
10 2 6 ,2 .5 6 . 100 243 m 401.0 670.7 +269.7
11 5,3,58. 100 216 F 393.7 524.9 +131.2
12 6 .3 .5 8 , 100 230 M
«116«
431.0 510,0 +79.0
Summary of Table 3ÜÜCVI*
m-Oresotiaie Acid,
Dose Mean A 0,
IS. mis./hr.'
- 32.6 
50 -5.3
62.5 +19.8
75 +70.0
87.5 +91.7
100 +97.8
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Table XllVII.
Oxygen coneimiption of rats after injection of para
cresotinie acid.
Dob6 Wt
O2 conBumption
mlso/hr. 
Control Treate<
Biff .AO
Mo. Bate ragms. gms • Sex (2) (1) (1)“(2)
1 30.9.57# 25 204 1 456.6 372.3 -84.3
2 8.10.57- 25 237 P 425.9 415.7 -10.2
3 9.10.57. 25 220 P 564.5 364.5 0
4 17.10.57. 25 228 F 379.1 308.8 +9.7
5 6*11.57. 25 220 I 382.5 367.2 "15.3
6 14.11.57'. 25 210 M 418.2 410.6 —7.6
7 26.11.57. 25 212 M 364.5 362.1 -2.4
8 11.12.57. 25 208 M 403.4 415.5 +12.1
1 2.10.57. 50 220 1 465.7 461.6 -5.1
2 7.10.57. 50 248 M 464.1 449.6 -14.5
3 10.10.57. 50 220 P 400.4 392.7 “7.7
4 14.10.57. 50 220 P 379.1 405.0 +26.7
5 8.11.57. 50 230 P 428.4 402.9 -25.5
6 27.11.57. 50 218 M 436.1 431.0 -5.1
7 28.11.57. 50 233 P 349.9 374.2 +24.3
8 2.12.57. 50 203 M 393.7 398.5 +4.8
1 19.12.57. 62.5 2X6 P 377.4 464.1 +86.7
2 10.1.58. 62.5 215 M 347.5 374.2 +26.7
3 14.1.5a. 62.5 220 1 385.1 377.4 -7.7
4 15.1.58. 62.5 232 m 374.2 405.8 +31.6
5 16.1.58. 62.5 202 M 339.2 344.3 +5.1
6 10.2.58. 62.5 200 F 396.1 393.7 —2.4
7 11.2.58. 62.5 200 P 369.8 461.5 +91.3
a 12.2.58. 62.5 180 f 379.1 464.1 +85.0
9 14.2.58. 62.5 175 M 367.2 482.0 +114.8
10 21.2.58. 62.5 195 P 349.4 448.8 +99.4
11 24.2.58. 62.5 245 M 398.5 469.0 +70.5
12 3.3.58. 62.5 205 P 401.0 422.8 +21.8
•lia.
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Table XXXVII. (contd.).
p-OreBotinie Acldo
• mlB ./hr. Biff .AO,
Dose wt. Control Treated mls./hr
Io« Date mgme. gms. Sex (2) (1) (l)-(2)
1 4.10.57. 75 227 1’ 415.5 486.0 +70.5
2 11.10.57. 75 204 F 428.4 451.4 +23.0
3 21.10.57. 75 215 P 377.4 443.7 +66.3
4 4.11.57. 75 245 m 461,7 473.9 +12 • 2
5 11.11.57. 75 203 M 430,1 490.9 +60.8
6 29.11.57. 75 210 1 415.7 591.6 +175.9
7 16.12.57. 75 205 1 359.6 380.0 +20. 4
8 17.12.57. 75 240 3? 425.3 427.7 +2.4
9 18.2.58. 75 230 M 341.7 479.4 +137.7
10 20.2.58. 75 215 M 401.0 490.9 +89.9
11 25.2.58. 75 220 3? 380.0 413.1 +33.1
12 27.2.58. 75 195 1? 354.8 357.2 +2 .4
1 20.12.57. 87,5 202 P 447.1 490.9 +43.8
2 9.1,50, 87,5 215 M 530.4 550,0 +20.4
3 13.1.58. 87.5 243 I? 398.5 456.8 +58,3
4 17.1.58. 87.5 202 M 369.8 425.9 +56.1
5 20.1.58. 87,5 210 M 398.5 498.2 +99.7
6 21.1.58. 87.5 202 F 420.8 494.7 +73.9
7 22.1.58. 87.5 245 M 415,5 410.7 “4.8
S 13.2.58. 87.5 180 I 321.3 510.0 +188.7
9 19.2.58. 87:5 190 F 330.5 442.3 +111.8
10 26.2.58, 87,5 230 M 380.0 459.0 +79.0
11 5.5*58. 87.5 195 F 336.6 408,0 +71.4
12 6.3,58. 87.5 250 M 359.6 634.2 +274.6
1 1.10.57. 100 214 3? 342.6 551.6 +209.0
2 15.10.57. 100 204 M 405.5 502.4 +96.9
3 18,10.57. 100 240 F 459.3 590,5 +131.2
4 5.11.57. 100 220 3? 385.1 507.5 +122.4
5 7.11.57. 100 212 M 483.6 507.9 +24.3
6 12.12,57. 100 240 3? 425.9 624.8 +198,9
7 .13.12.57. 100 225 H 391.2 605.1 +213.9
8 18,12.57. 100 205 1 388,9 437.4 +48.5
9 17.2.58, 100 200 1' 398.5 410.7 +12,2
10 2.3.58. 100 200 M 295.8 438.6 +142.8
11 4.3.58, 100 235 M 371.8 551.6 +179.8
12 7.3,58. 100 205 F 408.0 400.4 -7.6
2
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of Table XJCXYII.
p-CgesQt:lBic Acid
o lYJsaa a MWi « # *  M
Dose
50
62.5 
75
87.5 
100
Hoaa-Ù Op 
nils./te.
- 12.2
-0.3
+51.9
+57.9
+89.4
+114.4
.180.
gaglQ XUMITX. 
Ihe eff eet_of 150 mgms acid on the
n c onBurapt i om of rata•
Op coBBumption
IG, Bate
Weight
g-DlS, Sex
mis ./hr,
Coatrol Treated mis./hr. 
(2) (1) (l)-(2)
1 18,3,3i* # 5 M 284.3 466.6 +182.3
2 18,3,58, f 387,6 545,7 +158.1
3 19,3,58, 228 M 352.1 554,6 +172.5
4 20.3.58. 205 F 390.2 550.8 +160.6
5 21.3.58. 205 M 427.7 449,6 +21.9
6 21.3.58. 245 F 395.3 550.8 +155.5
7 24.3.58. 205 M 347.5 437.4 +89.9
8 25.3.58. 205 F 374.9 423.3 +48.4
9 26.3.58. 229 M 366.9 544,3 +177.4
10 26.3.58. 245 F 288.2 517.7 +229.5
11 27.3.58. 210 m 345.1 437.4 +92.3
12 28.3.58. 218 F 374.9 504.9 +130.0
13 31.3.58. 205 M 364.5 442.3 +77.8
14 1.4.58. 205 F 420.8 400 . 4 —20 . 4
2
Table XXX2Z.
The e f f e c t  o f 70 mmiBm o r th o o re e o tin io  a a ld  on the
« » g a e s s ^ t : r .a K n r= g s ^ ; ; B l : ~ a -s-»Baai-UKS5aar.-WJ^:* :M g ÆLJjji>l»iltv j- a a x J tg \p m iTO :'a ~iwg-ti:a a « w a » ;<t?,rara^ r-TT3 N = a «r=eJW =E::_ w = n c= R^_».' i« p »u j '.» = )
oxygen oonsimptlon of rata.
Mo, Date
Weight
gMBm Bess
mls./lsr. 
Control Treated 
(2) (1)
Dlff.A 0
ml8 . / h r ,  
(1)—(2)
1 1 8 ,3 .5 8 . 200 M 266,2 471,8 +205,6
. 2 1 9 .3 .5 B . 250 ]? 519,7 590.5 +70,8
3 1 9 .3 .5B. 205 m 362.1 499,8 +137.7
4 2 0 .3 .5 8 . 245 p 408.2 588.1 +179,9
5 2 1 .3 .5 8 . 200 M 323.3 453,9 +130.6
6 2 4 .3 .5 8 . 214 P 439,8 454,4 +14 • 6
T 2 4 .3 .5 8 . 202 M 362.1 476,9 +114,8
8 2 5 .3 .5 8 . 226 f 413,1 478.7 +65.6
9 2 6 .3 .5 8 . 218 M 349,4 540.6 +191,2
10 27.3.58. 235 P 325,6 568.6 +243,0
11 2 7 .3 .5 8 . 200 M 357.0 476.9 +119.9
12 3 1 .3 .5 8 . 200 2? 437.4 466.5 +29.2
13 3 1 .3 .5 8 . 200 1 392,7 507,5 +114,8
14 1 .4 .5 8 . 245 P 461.7 498.2 +36.5
•122
and 35 mgms. ortîiooreBOtinie acid on the oxygen 
coneuffiption of rate.
I'o. 35ate
Weight 
gms. Sez
\j V/AAtO Ü JhWAA
ml s./hr. 
Control Treated 
(2) (1)
Mff , AO
mis./hr. 
(1)-(2)
1 18.3.58. 200 M 286.7 337.8 +51.1
2 19.3.58. 245 f 390.2 545.7 +155.5
3 20.3.58. 210 M 362.1 515.2 +153,1
4 20.3.56. 205 3? 298.4 420.8 +122.4
5 21,3.58. 200 M 349.9 386.4 +36.5
6 24.3.58. 200 F 377.4 448.8 +71.4
7 25.3.58. ■ 202 M 359.6 461.7 +102.1
8 25.3.58. 200 1? 377.4 497.3 +119.9
9 26.3.58. 245 M 320.8 583.2 +262.4
10 27.3.58. 210 f 413.1 530.4 +117.3
11 20.3.58. 202 M 455.8 590.5 +133.7
12 31.3.58. 200 f 441.2 510.0 +68.8
13 1.4.58. 205 1 386.4 510.3 +123.9
14 1.4.58. 205 F 397.8 471.8 +74.0
'I23.
Table SLl..
A compariaoai of the effect of 150 mgiES, aalioyllj 
acid a M  of 70 mgma, ortliooresotinic aaid on the 
oxygen conenmptlom of rata.
tza cce ^& *% W B *R k*ca 3 K :6 g sa r« cwjk.:;j^»L;j,6ÆaavT(:^%3MeÆaa!!g3KTCSTTnfi&azTii5=zc:i.'3r='3
Trial Salicylic Acid Or-thocresotinic Acid liils./hr
lo. àOp ails./hr. (s) AOg inla./hr.(0) (S)“(0)
1 +182.3 +205.6 -23.3
2 +158.1 +70.8 +87.3
3 +172.5 +137.7 +34.8
4 +160.5 +179.9 -19.3
5 +21.9 +130.S -108.7
6 +155.5 +14.6 +140.9
7 +89.9 +114.8 —24.9
8 +48.4 +55.5 -17.2
9 +177.4 +191.2 -13.8
10 +229.5 +243.0 -13.5
11 +92.3 +119.9 -27.6
12 +130.0 +29.2 +100.8
13 +77.8 +114.8 -37.0
14 —20.4 +36.5 -56.9
Average +119.7 +118.1 +1.6 +38.52
H„ accepted (Z, ~ 0.008).
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Table XMI.
A comparison of  the  e f f e c t  o f  150 mgrns. B a l icyX ic  ac id  
a M  o f a m ix t u r e o f  75 mmia. e a l i o j l i c  a c id   ^ 35 mgms » 
0">er© sotia io  a c id  on th e  oxygen consumption o f  r a t e .
B i f f
Trial Salioylie Aeid 
lo. ûOp mis./hr.(S)
Mixture mis./hr. 
AOg mis./hr.(80) (S)-(SO)
1 +182.3 +51.1 +131.2
2 +158.1 +155.5 +2.6
3 +172.5 +153.1 4% 9 # 4
4 +160.6 +122.4 ^^ 38.2
5 +21.9 +36.5 —X4 • 6
6 +155.5 +71.4 4'84 • X
? +89.9 +102.1 -12.2
8 +48.4 +119.9 -71.5
9 +177.4 +252.4 -85.0
10 +229.5 +117.3 . m a .  2
11 +92.3 +133.7 «•41 • 4
12 +130.0 +68.8 +61 .2
13 +77.8 +123.9 — 46  .1
14 —20.4 +74.0 —9 4 .4
Average +119.7 +113.7 +6.0 +41.59#
o accepted {z - 0 .1 0 3 ) .
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Table lliîll.
A ooraparlBon of the effect of 70 mgme» ortho ore sot ini 
acid and of a mixture of 75 mm#, sal 1 oy 11 o__aald _t 
o-creBOtinlc acid on the oscyg
lo
Orthoeresotinie Acid 
AOg nilB./hr*(0)
Mixture 
AOg m is ./h r ,(B O )
Biff, 
mls./lir.
'  M B  ■
1 +205.S +51,1 +154.5
2 +70.8 +155.5 -84.7
3 +137.7 +153.1 —15,4
■ 4 +179,9 +122.4 +57.5
5 +130.6 +36.5 +94,1
6 +14 . 6 +71.4 -56.8
? +114,8 +102.1 +12.7
.8 +65,6 +119.9 -54,3
9 +191.2 +262.4 -71,2
10 +243,0 +117.3 +125,7
11 +119.9 +133.7 -13.8
12 +29,2 +68.8 -39.6
13 +114*8 +123.9 -9,1
14 +36.5 +7 4.0 -37,5
Average +118.1 +113.7 +4,4 ^43,46
accepted {% - 0.052).
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Table
Plasma concentration after injection of 150 mgmo »
to rata#
Date
Weight 
gms. Seic
Time
hrs.
Plasma Coae. 
mgvas.jâ
Plasma Gome 
m. I'iQ, ./3j.
16.10.57. 258 1 .25 103 7.46
16.10.57. 236 I .25 114 8.26
23.12.57. 208 m .25 127 9.20
23.12.57. 255 3? .25 124 8.99
20.2.58. 370 M .25 83 6.01
20.2.58. 270 f .25 102 7.39
25.3.58. 247 M .25 123 8.88
25.3.58. 244 1 .25 102 7.39
28.10.57. 290 il .50 100 7.25
28.10.57. 216 f .50 130 9.42
15.11.57. 276 M .50 101 7.32
15.11.57. 252 F .50 114 8.26
25.2.58. 280 ffi .50 100 7.25
25.2.5a. 260 F .50 105 7.61
26.2.58. 280 M .50 98 7.10
26.8.58. 185 f .50 148 10.72
23.12.57. 260 M 1.0 60 4.35
23.12.57. 200 3? 1.0 114 8.26
19.2.50. 330 1 1.0 89 6.45
19.2.58. 215 1 1.0 120 8.70
26.3.58. 270 M 1.0 100 7.25
26.3.58. 235 F 1.0 112 8.12
2.4.58, 295 M 1.0 95 6.88
2.4.58, 200 i* 1.0 124 8.99
27.12.57. 306 M 2.0 82 5.94
27.12.57, 236 f 2.0 60 4.35
28.12.57, 233 M 2.0 103 7.46
28.12.57. 237 F 2.0 104 7.54
27.3.58. 315 M 2.0 76 5.51
27.3.58, 220 P 2.0 87 6.30
1..4.58. 290 M 2.0 90 6.52
1.4.58. 205 P 2.0 108 7.83
contd•
'12?.
Table XLIYe (contd»)
Weight Tiiaa Plasma Coae. Plasma Go:
Date gras. Sex hrs. mgms.î^ ra.Eg,./ïi
6.12.57. 205 M 4.0 94 6.81
6.12.57". 238 W 4.0 77 5.58
14,1.58. 380 m 4.0 65 4.71
14.1.58. 205 f 4.0 82 5.94
26.2,58. 290 M 4.0 75 5.43
26.2.58. 210 F 4.0 88 6.38
27.3.58. 250 H 4.0 88 6.38
27.3.58. 230 f 4.0 91 6.59
25.10.57. 245 F 6.0 65 4.71
24.12.57. 230 M 6.0 78 5.65
24.12.57. 203 f 6.0 95 6.88
30.12.57. 243 M 5.0 80 5.80
30.12.57. 274 f 6.0 54 3.91
25.3.58. 257 M 6.0 59 4.27
25.3.58. 234 F 5.0 64 4.64
26.3.58. 208 M 6.0 78 5.65
26.3.58. 216 F 6.0 Dea^ «
29.10.57. 312 M 8,0 54 3.91
29.10.57. 256 F 8.0 65 4.71
14.1.58. 301 H 8.0 54 3.91
14.1.58. 226 F 8.0 67 4.85
25.2.58. 280 ffi 8.0 64 4.64
25.2.58. 255 F 8.0 40 3.33
1.4.58. 290 M 8.0 70 5.07
1.4.58. 220 F 8.0 80 5.80
29.10.57. 300 M 16.0 35 2.54
29.10.57. 172 F 16.0 Doaâ.
18.2.58. 200 1 16.0 43 3.12
18.2.58. 205 f 16.0 44 3.19
20.2.58. 350 1 16.0 42 3.04
20.2.58. 255 F 16.0 45 3.26
1.4.58. 200 F 15.0 50 3.62
2.4.58. 290 M 16.0 34 2.46
2.4.58. 230 F 16.0 41 2.97
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Tlse
hrs.
.25
.50
1.0
2.0
4.0
6.0 
8.0
16.0
Plasma Cone 
mgms.S^
110
112
102
89
72
62
42
Plasma Gone. 
m.3ilq../L.
8.11
7.57
6.45
5.19
3.0:
Table x m .
Pj.agma Goncentratlon after 100
ortho-cr’esotinic acid to rate*
Weight Time Plasma Goao. Plasma Oo]
Date gras. Sex tes. rflgms.5^ m.Eq./li
28.10.57. 326 M .25 84 5.53
28.10.57. 192 P .25 108 7.10
15.11.57. 225 M .25 100 6.58
15.11.57. 240 P .25 99 6.51
26,2.58. ISO 1 .25 119 7.83
26.2.58, 203 .¥ .25 100 6.58
27.3.58. 325 M .25 88 5.79
27.3.58, 200 F .25 140 '9.21
16.10.57. 228 m .50 97 6.38
16,10.57, 253 F .50 90 5.92
23.12.57. 261 M .50 96 6.32
23.12.57. 268 F .50 102 6.71
20,2.58. 265 ■ 1 .50 92 6.05
20.2.58. 235 F .50 102 • 6.71
25.3.58. 234 M .50 112 7.37
25.3.58. 216 F .50 125 8.22
27dl2.57. 220 H 1.0 104 6.84
27.12.57. 256 F 1.0 98 6.45
28.12.57. 294 M 1.0 92 6.05
28.12.57. 236 F 1.0 105 6.91
25.2,58. 297 M 1.0 82 5.39
25.2.58, 205 F 1.0 114 7.50
1.4.58, 315 M 1.0 87 5.72
1.4.58. 215 F 1.0 122 8.03
23.12.57. 205 M 2.0 94 6.18
23.12,57. 296 f 2.0 96 6.32
19.2.58. 320 M 2.0 ■70 4.61
19.2.58. 230 F 2.0 90 5.92
26.3.58. 234 M 2.0 110 7.24
26.3.58. 196 F 2.0 Died.
26.3.58. 245 F 2.0 105 6.91
2.4.58. 200 H 2.0 116 7.63
2.4.58. 215 F 2.0 121 7.96
contd»
Table XXj?» ( contd • ) « 
0-Or 08 O t inioÂoM •
Weight Time Plasma Ooae. Plasma Coî
Date giBS, Sex tes. agms.jJ m.Bq./D,
25.10.57 247 f 4.0 80 5.26
24.12.57. 205 1 4*0 92 6.05
24,12.57, 240 F 4.0 78 5.13
14.1.58. 310 M 4.0 70 4,60
25,3.58. 258 M 4.0 86 5.66
25.3.58. 268 P 4.0 65 4,22
26,3,58. ■ 320 M 4.0 70 4.61
26,3.58, 215 J!' 4.0 83 5.46
25.10.57. 233 f 6.0 75 4,93
6.12.57, 212 M 6.0 68 4.47
6.12.57. 245 f 6.0 80 5,26
14.1.50. 290 M 6.0 66 4.34
26.2.58. 295 m 6.0 67 4.41
26.2.58, 205 F 6.0 Med.
27,3.58, 325 m 6.0 5.07
27.3.58. 240 F 6.0 Died.
3.4.58. 240 F 6.0 70 4.60
3.4.58. 215 F 6.0 83 5.46
29.10.57. 298 M 8.0 47 3.09
29.10.57. 265 F 8.0 64 4.21
18.2.58, 320 ffi 8.0 52 3.42
18.2,58. 210 F 8.0 66 4.34
20,2.58. '285 M 8.0 58 3.82
20,2.58. 240 f 8,0 57 3.75
2.4.5s, 240 M 8.0 90 5.92
2,4.58, 235 F 8.0 72 4.73
29.10.57. 322 ffi 16.0 33 2.17
29.10.57. 192 F 16.0 Died.
30.12.57. 232 M 16.0 28 1.84
30.12.57. 268 F 16,0 46 3,03
25.2.58. 310 , M 16.0 40 2 ,63
25.2.58. 245 F 16.0 49 3.22
1.4.58. 280 M 16,0 50 3.29
1.4.58. 230 F 16.0 47 3.09
2.4.58., 245 F 16.0 43 2.83
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mmary of Table XL¥,
BrrJi.iii. rum cM wm
f; 
hre •
.25
.50
1.0
2.0
4.0
6.0 
8.0
16.0
Moan 
Plaama Cone. 
10.aw /D
105
102
100.5
100
78
63
41
Plasma Cone. 
m.Bci./Xi.
5,89 
6.71 
6,51
6,60
5.12 
4.82 
4,16 
2,76
Table XIiVl.
Plaema aoneentration after Injection of 100 
ïïieta-oreaotinio aoiâ to rata.
Date
Weight
gias. Sex
Time
tes.
Plasma Conc. 
mgms ,io
Plasma Oo: 
m,Eg../L
23.12,57. 260 M .25 88 5.79
23.12.57. 254 F .25 93 6.12
19.2.58. 360 M .25 72 4.74
19,2.58. 275 F .25 90 5.92
26.3.58. 218 M .25 102 6.71
25.3.58. 210 F .25 117 7.70
2.4.58. 225 1 .25 91 5.99
2.4.58. 200 F .25 125 8.29
27.12.57. 208 m .50 113 7.43
27.12.57. 232 F .50 107 7.04
28,12.57. 252 M .50 98 6.45
28,12.57. 240 F .50 106 6.97
27.3.58, 330 M .50 88 5.79
27.3.58. 200 F .50 135 8.88
1.4.58. 260 M .50 93 6.12
1.4.58. 210 F .50 117 7.70
16.10.57. 288 M 1.0 72 4.74
16.10,57. 230 F 1.0 90 5.92
23.12,57. 230 M 1.0 90 5.92
23.12.57. 246 F 1,0 94 6.18
20.2.58. 320 M 1,0 76 5.00
20.2.58. 230 F 1.0 99 6.51
25.3.58. 258 M 1.0 85 5.59
25.3.58. 266 F 1.0 90 5.92
28.10.57. 292 M 2.0 68 4.47
28.10.57. 204 F 2.0 103 6.78
15.11 .,57. 272 M 2.0 75 4.93
15.11.57. 264 F 2.0 78 5.13
25.2.58. 310 ffi 2.0 72 4.74
25.2.58. 215 F 2.0 88 5.79
26.2.58. 285 M 2.0 81 5.33
26.2.58. 177 F 2.0 Died.
3.4.58. 210 F 2.0 114 7.50
coîitd.
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Table XD¥I» (oontd*)
ii-OroBotisiio Aold.
S!i. Time Dlasma Clone» Plasma Gone
Date gras. Sex hrs. mgas.jS m.ïia./l
29.10.57. 306 M 4.0 66 4.34
29.10.57. 198 F 4.0 87 5.72
50.12.57. 244 H 4.0 68 4.47
30,12,57. 243 F 4.0 80 5.26
25.2.58. 248 M 4.0 69 4.54
25.2.58. 245 f 4.0 72 4.74
1.4.58, 345 M 4.0 60 3.95
1.4,50. 205 F 4.0 76 5.00
29.10.57. 282 M 6.0 56 3.68
29.10.57. 206 F 6.0 69 4.54
18.2.58. 285 M 6.0 54 3.55
18.2,58. 205 F 6,0 76 5.00
20.2.58, 225 1 6.0 70 4,60
20.2,58. 225 F 6.0 72 4.74
2.4.58, 240 M 6.0 72 4.74
2.4.58. 210 F 6.0 90 5.92
6.12,57. 203 M 8.0 49 3.22
6,12,57. 270 F 8.0 65 4.28
14.1.58. 232 m 8.0 59 3.88
14.1.58. 206 F 8.0 73 4.80
26.2.58, 220 M 8.0 56 3.68
26.2.58. 225 F 8.0 84 5.53
27.3.58. 285 M 8.0 57 3.75
27.3.58. 245 F 8.0 61 4.01
24.12.57. 238 1 16.0 29 1.91
24.12.57. 242 F 16.0 34 2.24
14.1.58. 220 M 16.0 30 1.97
14.1,58. 218 F 16.0 24 1.58
25.3,58. 222 M 15.0 31 2.04
25.3.58. 220 F 16.0 28 1.84
26.3,58. 314 M 16.0 40 2.63
26,3,58. 234 F 16.0 52 3.42
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of Table X M l
m-Gresotinic Add.
■ e w w e a w w m s e e
Time
tes.
.25
.50
1.0
2.0
4.0
6.0 
8.0
Plasma Oono,
■• yo
97
107
85
72
69
Mean 
Plasma Gone, 
m. E(|,. /ij.
6.41
7.05
5.72
5.
33
4.75
4.60
4.14
2.20
135'
Table XMII.
Plasma concentrât i on after Inj e et ion of 100 m m s , 
oara-GresotInlo aoid to rats.
Weight Time Pla.sma Gone. Plasma Oo:
Date gms, Sex hre. mgma •/) ra.Bci./ïi
27.12.57. 215 M .25 102 6.71
27.12.57. 220 I .25 96 6.32
28.12.57. 252 M .25 84 5.53
28.12.57. 258 P .25 80 5.26
25.2.58. 270 M .25 86 5.66
25.2.58. 235 P .25 88 5.79
1.4.58. 245 m .25 90 5.92
1.4.58. 220 p .25 114 7.50
23.12.57. 274 M 84 5.53
2 3 . 1 2 , 5 7 . 268 P ,50 82 5.39
19.2.58. 270 m .50 88 5.79
19.2.58, 260 w .50 88 5.79
2 6 . 3 . 5s , 225 m .50 96 6.32
2 5 . 3.580 200 p .50 S3 5.46
2 ,4 .5 8 , 220 M \.5 0 104 6.84
2,4.58, 200 F .50 130 8.55
2 8 .1 0 ,5 7 . 274 M 1 .0 78 5.13
2 8 .1 0 ,5 ?0 204 F 1 .0 102 6.71
15,11,57. 274 M 1 .0 78 5.13
15.11.57. 231 F 1 .0 97 6.38
2 6 ,2 .5 8 . 215 M 1 .0 96 6.32
2 6 , 2 . 5a . 185 F 1 .0 111 7.30
27.3.58, 325 M 1.0 76 5.00
27,3.58, 205 F 1 ,0 110 7.24
16,10.57. 240 M 2 .0 81 5.33
1 6 .1 0 ,5 7 . 236 F 2.0 93 6.12
23.12.57. 239 M 2.0 84 5.53
23.1 2 057. 262 F 2.0 95 6.25
20.2,58. 270 1 2.0 75 4.93
2 0 .2 .5 8 , 250 F 2.0 90 5.92
25.3c'58, 257 M 2.0 78 5.13
25.3.58, 234 F 2.0 94 6.18
contd
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Table ZI,VII. (coaM.) 
Acid.
Weighs Tiras Plasma Gone. Plasma Co;
Date gms. Sex hrs. ragms.5^ ■ m.lçs,./D
29.10.57. 264 M 4.0 64 4.21
29.10.57. 222 P 4.0 98 6.45
18.2.58. 315 M 4.0 64 4.21
18.2.58. 205 1 4.0 83 5.46
20.2.5s. 275 ' M 4.0 67 4.41
20.2.58. 215 f 4.0 88 5.79
2.4.58.- 265 M 4.0 71 4.67
2:4.58. 205 P 4.0 97 6.38
29.10.57. 316 M 6.0 72 4.74
29.10.57. 248 P 6.0 65 4.28
24.12.57. 257 1 6.0 50 3.29
24.12.57. 240 F 6.0 72 4.74
25.2.58. 305 M 6.0 54 3.55
25.2.58. 190 f 6.0 Died,
1.4.58. 290 M 6.0 64 4.21
1.4.58. 210 P 6.0 70 4.60
3.4.58, 230 P 6.0 84 5.53
30.12.57: 253 M 8,0 54 3.55
30.12.57. 282 f 8.0 46 3*03
14.1.58. 248 M 8.0 58 3.82
14.1.50, 204 P 8.0 Died.
25.3.58. 230 M 8.0 58 3.02
25.3.58. 182 P 8.0 Died.
26.3:58. 260 M 8.0 63 4.14
26.3.58. 228 f 8.0 74 4.87
3.4.58. 235 P 8.0 84 5.53
3.4.58. 235 P 8.0 68 4.47
6.12.57. 297 1 16.0 30 1.97
6.12.57. 260 P 16.0 44 2.89
14.1.58. 325 H 16.0 19 1.25
14.1,58, 251 I* 16.0 ' 38 2.50
26.2.58. 320 M 16.0 34 2.46
26.2.58, 210 F 15.0 Died.
27.3.58. 275 M 16.0 38 2.50
27.3.50. 280 P 16,0 50 3.29
27.3.58. 200 f 16.0 58 3.82.
Siimîaary of Table Xliflî
[’Gsotiaic Aoifl.
Meaa
Time Plasma Gone. Plasma Gone
hrs. mgitts.s^  m.Bq./D.
.25 95 6.09
.50 94 6.21
1.0 95 6.15 .
2.0 86 5.67
4.0 79 5.20
6.0 66 4.37
8.0 65 4.15
16.0 59 2.59
Table ZLTIII.
She effect of 50 mgms. 3~ph©îi.vlsalicylio acid oxi
the oxygen consumption of Wletar albino rats,
m im # i  ■ » w m n f , t i M u m i i p f  I g i I , j u i.  m i l . . 11 I , . I  I I I  »',L .M
lo. Bate Sex
Weight
gms.
mis./te. 
i Control Treated 
(2) (1)
Diff.A 0
mis./te. 
(1)“(2)
1 6,2,58. M 255 415.5 617.2 +201.7
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